[
  {
    "miRNA_name": "Family (miR-200a,200b,200c,miR-141,miR-429)",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: predictor of aggressiveness of GC",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "46 paired tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26137064"
  },
  {
    "miRNA_name": "Family (miR-200b,miR-200a,miR-429)",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p=0.003(miR-200b),p=0.001(miR-200a),p=0.037(miR-429)",
    "sample_type": "Tissue",
    "sample": "88 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7a-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Predict prognosis",
    "expression": "Downregulated",
    "significance": "p=0.024",
    "sample_type": "Serum Tissue",
    "sample": "192 CRC patients,  serum and tumour tissues",
    "continent": "Asia",
    "population": "Taiwan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27262492"
  },
  {
    "miRNA_name": "let-7c",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic Indicator",
    "expression": "Upregulated",
    "significance": "p=0.011",
    "sample_type": "Serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "let-7g",
    "cancer": "Rectal Cancer",
    "marker": "Prognostic",
    "marker_details": "High expression of let-7g was associated with better DFS",
    "expression": "Upregulated",
    "significance": "p=0.028",
    "sample_type": "Tissue",
    "sample": "128 pretherapeutic biopsies of rectal cancer patients treated with 5FU",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932154"
  },
  {
    "miRNA_name": "let-7g",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-worse OS for low expression(p=0.0027)",
    "expression": "Downregulated",
    "significance": "p<0.0001(tissues)",
    "sample_type": "Tissue Cell-line",
    "sample": "90 paired tissues,GES1,MKN28,SGC7901,NCI-N87,BGC-823,AGS,HGC27",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28493075"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic  for LPFs,DPFS &OS(multivariate analysis)",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "120 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25218280"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "101 surgical tissues,3ESCC cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292834"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall survival",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "138 pairs of human CRC and adjacent normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25216869"
  },
  {
    "miRNA_name": "miR-100-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues.",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RNA deep sequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic factor of overall survival (HR=0.550, 95% CI: 0.351-0.863) and disease free survival(HR=0.562, 95% CI: 0.397-0.794)",
    "expression": "Upregulated",
    "significance": "Increased gradually from normal mucosa, adenoma to stage I  (p<0.01), and decreased gradually from stage II to stage IIII (p<0.01)",
    "sample_type": "Tissue",
    "sample": "Tissues (Tissue microarrays containing 56 specimens of normal mucosa, 51 adenoma and 735 colorectal cancer and  5 specimens of normal mucosa, 5 adenoma and 47 colorectal cancer for Real time PCR), CRC cells",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25940181"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC-0.548,plasma miR-103 level is not a biomarker for DGC",
    "expression": "No Significant Difference",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Diffuse type gastric cancer(DGC), plasma-50 DGC and healthy control",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27909811"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Prognostic-high expression had poor OS & DFS for Gc patients",
    "expression": "Upregulated",
    "significance": "p<0.05(tissues)",
    "sample_type": "Tissue Cell-line",
    "sample": "92 primary Gc,20 adjacent non tumorous tissues,SGc7901,MKN45,BGC823",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28445396"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival",
    "expression": "Upregulated",
    "significance": "For survival p=0.007",
    "sample_type": "Tissue",
    "sample": "38 CRC tissues and the paired adjacent normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27602163"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "70 patients and CRC cell lines: Caco-2, SW480, HT-29, HCT-116, LOVO and HCEpic cells",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24393525"
  },
  {
    "miRNA_name": "miR-103a-3p",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker: high-risk groupregulated had significantly shorter disease-free survival",
    "expression": "Upregulated",
    "significance": "p=0.023",
    "sample_type": "Tissue",
    "sample": "Tumor samples from 71 white patients with stage II colon cancer",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "--",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247088"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC curve was 0.895 (95% CI: 0.846~0.943), specificity-93.8% and sensitivity-77.5%",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "sample_type": "Plasma",
    "sample": "80 GC & 60 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-flourescent PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26722506"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Significantly decreased after the operation",
    "expression": "Upregulated",
    "significance": "p=0.012, sensitivity of 62.3%, and a specificity of 68.2%",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 50 colorectal cancer patients and 47 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24670448"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "expression": "Upregulated",
    "significance": "p<0.05(tissue and plasma)",
    "sample_type": "Tissue Plasma",
    "sample": "28 pairs of GC  and adjacent tissues, 48 pairs of plasma samples before and after operation from GC patients, and 22 plasma samples from healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR,MSP",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26179261"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker",
    "expression": "Upregulated",
    "significance": "p<0.05(tissue and plasma)",
    "sample_type": "Tissue Plasma",
    "sample": "28 pairs of GC  and adjacent tissues, 48 pairs of plasma samples before and after operation from GC patients, and 22 plasma samples from healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR,MSP",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26179261"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "81 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24314216"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Downregulation of miR-106a predicted shortened DFS (P = 0.03) and OS (P = 0.04)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "--",
    "sample": "110 colon cancer patients",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18521848"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non-invasive marker to identify colorectal cancer patients from among those with negative iFOBT results",
    "expression": "Upregulated",
    "significance": "p=0.001",
    "sample_type": "Stool",
    "sample": "Fecal samples from 117 colorectal cancer patients and 107 healthy volunteers",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23950216"
  },
  {
    "miRNA_name": "miR-106a*",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26314198"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.856 with 75.0% sensitivity and 92.5% specificity for discriminating GC patients from controls, AUC of 0.700 with 87.2% sensitivity and 45.0% specificity for discriminating GC from BGD patients and  AUC of 0.739 with 75.0% sensitivity and 68.7% specificity for discriminating BGD patients from controls",
    "expression": "Downregulated",
    "significance": "p=0.000(Gc vs healthy),p=0.002(BGD vs healthy),p=0.001(Gc vs BGD)",
    "sample_type": "Serum",
    "sample": "40 GC,32 benign gastric disease(BGD) & 36 healthy sera",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561770"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "180 colonic cancer cases",
    "continent": "Asia",
    "population": "China",
    "detection_method": "in situ hybridization (ISH)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25755775"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall and disease free survival",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Surgical specimens of cancer tissue and adjacent normal mucosa from 95 patients",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26223867"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "High miR-106b stromal expression in in GC is associated with decreased overall survival(p=0.03)",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "GC fibroblasts,normal fibroblasts",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24842611"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "expression": "Upregulated",
    "significance": "p=0.028",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC-0.563, plasma miR-107 level is not a biomarker for DGC",
    "expression": "No Significant Difference",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Diffuse type gastric cancer(DGC), plasma-50 DGC and healthy cobtrol",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27909811"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with Progression-free survival (PFS) and disease free survival",
    "expression": "Upregulated",
    "significance": "p=0.026",
    "sample_type": "Tissue",
    "sample": "Tumor tissue samples of 78 patients",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC= 0.72(95% CI:0.62-0.83,sensitivity=70%,specificity=84%",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma",
    "sample": "50 ESCC and 50 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26554762"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall survival (P < 0.0001)",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "246 pairs of samples, Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "rea time PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27592860"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : in stage I,II,III 5 year survival rate with high miR-10b exp. Was significantly lower than with low miR-10b exp.",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "56 gastric tumor tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "reverse transcriptase-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23351547"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Patients with high levels of miR-10b expression in their metastatic disease have a shorter time to event",
    "expression": "Downregulated",
    "significance": "p=0.00052",
    "sample_type": "Tissue",
    "sample": "78 samples (23 normal colon mucosa, N; 31 primary colon carcinoma, T; and 24 liver metastases, M), obtained from 46 patients",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23987127"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-10b associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "88 colorectal cancer cases",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-1207-5p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: expression inn GC not  correlates with survival time of patients",
    "expression": "Downregulated",
    "significance": "p=0.0015",
    "sample_type": "Tissue",
    "sample": "58 paired GC & adjacent corresponding tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481448"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC for plasma miR-122=0.808(95%CI,0.712-0.905,p<0.01)",
    "expression": "Downregulated",
    "significance": "p<0.01( GC/DM  vs GC/NDM & HC group plasma)",
    "sample_type": "Plasma",
    "sample": "GC,DM,NDM plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481716"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic:  higher plasma miR-122 in GC is a favourable Prognosis",
    "expression": "Downregulated",
    "significance": "p<0.01( GC/DM  vs GC/NDM & HC group plasma)",
    "sample_type": "Plasma",
    "sample": "GC,DM,NDM plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481716"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis and shorter relapse-free survival and overall survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma samples of 543 CRC patients with stage I-IV disease",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "Custom TaqMan® Array MicroRNA Cards followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27632639"
  },
  {
    "miRNA_name": "miR-1224-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor OS",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "99 mCRC patients, out of 99 33 patients had wild-type KRAS/BRAF and third- to sixth-line anti-EGFRmAb treatment",
    "continent": "Europe",
    "population": "Finland",
    "detection_method": "Microarray and qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23098991"
  },
  {
    "miRNA_name": "miR-1225-5p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival(p=0.003)",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue Cell-line",
    "sample": "60 paired GC & adjacent non tumor tissues,BGC-823,MKN-28,MKN-45,AGS,MGC-803,SGC-7901,NGEC",
    "continent": "Asia",
    "population": "China",
    "detection_method": "miRNA microarray,qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26684358"
  },
  {
    "miRNA_name": "miR-1229",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Could discriminate non-LNM from LNM with 80.0% sensitivity and 80.0% specificity and discriminate tumor Ι-II stages from tumor III-IV stages with 71.9% sensitivity and 75.0% specificity at the best cut-off value of 0.0125",
    "expression": "Downregulated",
    "significance": "p<0.000",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic Indicator",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "88 GC and adjacent normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28829503"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic :expression not correlated with patients prognosis",
    "expression": "Downregulated",
    "significance": "p=0.0001(tissues),p<0.05(cell lines)",
    "sample_type": "Tissue Cell-line",
    "sample": "80 gastric carcinoma tissues, 18 nontumourous gastric tissues ,MKN28,BGC823,MKN45,SGC7901",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24614175"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic Marker: correlated with worse prognosis, both in terms of overall survival and disease-free survival",
    "expression": "Downregulated",
    "significance": "p=0.001",
    "sample_type": "Tissue",
    "sample": "96 colorectal cancers and individual-matched normal mucosa samples",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22885837"
  },
  {
    "miRNA_name": "miR-124-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Plasma",
    "sample": "71 colorectal cancer patients, Plasma and FFPE samples",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25081869"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Serum miR-1246 is a diagnostic (AUC-0.754) biomarker",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Serum Cell-line",
    "sample": "101 ESCC serum,46 healthy serum, exosomes & donor cells of exosomes (TE1,TE2,TE4,TE6,TR11,WI38,MRC5)",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23361059"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Serum miR-1246  is a prognostic biomarker ,serum expression level,tumor depth,lymph node metastasis(all p<0.0001),distal metastasis(p=0.0005) are correlated with patients survival.",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Serum Cell-line",
    "sample": "101 ESCC serum,46 healthy serum, exosomes & donor cells of exosomes (TE1,TE2,TE4,TE6,TR11,WI38,MRC5)",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23361059"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-124a",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Potential risk marker of colitis-associated cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Forty UC patients without CAC, four patients with CAC or dysplasia, eight sporadic colorectal cancer (S-CRC) patients, and 12 healthy volunteers (HV)",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "methylation-specific polymerase chain reaction (MSP)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24825593"
  },
  {
    "miRNA_name": "miR-125a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Hypermethylated promoter-shorter overall survival (OS)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues,  CRC tissues and adjacent normal tissues from 68 CRC patients",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall survival (OS)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "68 CRC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Worse survival",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26398444"
  },
  {
    "miRNA_name": "miR-125a-3p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low expreesion related with poor prognosis(p=0.0083)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "70 paired GC & normal tissues",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322911"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had shorter OS & DFS ( both p<0.001) than with high expression",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Cell-line",
    "sample": "36 paired tissues,cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26504803"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Hypermethylated promoter-shorter overall survival (OS)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues,  CRC tissues and adjacent normal tissues from 68 CRC patients",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall survival (OS)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "68 CRC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "expression": "Upregulated",
    "significance": "p=0.001",
    "sample_type": "Tissue",
    "sample": "132 GC & 38 non cancerous gastric tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "High miR-125b expression group had a significantly poorer prognosis compared to the low expression group",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "89 colorectal cancer patients who underwent surgery",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21399871"
  },
  {
    "miRNA_name": "miR-125b-1",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Negatively associated with overall survival",
    "expression": "N/A",
    "significance": "p=0.040",
    "sample_type": "Tissue",
    "sample": "Pretreatment cancer tissues in a phase I study and cancer tissues in a phase II study, in which peptide vaccines combined with chemotherapy were given",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "Microarray followed by Revese transcription PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28859241"
  },
  {
    "miRNA_name": "miR-125b-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RNA deep sequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Low expression associated with poor survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "FFPEtissue from the primary tumours of 560 patients",
    "continent": "Europe",
    "population": "Denmark",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25199818"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "expression": "Upregulated",
    "significance": "p<0.0001, PPV=90%, and NPV=71%",
    "sample_type": "Tissue",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "continent": "Europe",
    "population": "Denmark",
    "detection_method": "In situ hybridization (ISH)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic Indicator",
    "expression": "Upregulated",
    "significance": "p=0.002",
    "sample_type": "Plasma",
    "sample": "Blood samples (plasma)  68 metastatic colorectal cancer patients",
    "continent": "Europe",
    "population": "Denmark",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25584492"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with longer progression-free survival",
    "expression": "Upregulated",
    "significance": "p=0.005",
    "sample_type": "Tissue Blood",
    "sample": "Phase III Nordic ACT (I) multicentre study included 249 patients from Sweden and Denmark, Tissues from 230 patients and blood from 222 patients",
    "continent": "Europe",
    "population": "Sweden and Denmark",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23922111"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "Tissue samples were obtained from surgical specimens from 66 patients (36 men, 30 women)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20680522"
  },
  {
    "miRNA_name": "MiR-126",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic facto for overall survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "92 pairs of CRC and adjacent nontumorous tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24532280"
  },
  {
    "miRNA_name": "miR-1260b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "120 cases of CRC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27399918"
  },
  {
    "miRNA_name": "miR-1266",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: higher miR-1266 exp. In GC tissues correlates with a longer survival time",
    "expression": "Downregulated",
    "significance": "p=0.0288",
    "sample_type": "Tissue",
    "sample": "58 paired GC & adjacent corresponding tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481448"
  },
  {
    "miRNA_name": "miR-1269",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic value of miR-1269a for disease-free survival was significant (p=0.015)",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "100 stage II CRC patients, early- and late-stage CRC tumors",
    "continent": "USA",
    "population": "USA",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25872451"
  },
  {
    "miRNA_name": "miR-127-5p",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-1287",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Low sensitivity and specificity",
    "expression": "Upregulated",
    "significance": "p>0.05 (not significant)",
    "sample_type": "Tissue",
    "sample": "40 pairs of CRC tissue samples and adjacent noncancerous tissues",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27251300"
  },
  {
    "miRNA_name": "miR-1287",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Low sensitivity and specificity",
    "expression": "Upregulated",
    "significance": "p>0.05 (not significant)",
    "sample_type": "Tissue",
    "sample": "40 pairs of CRC tissue samples and adjacent noncancerous tissues",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27251300"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC=0.639(miR-129-1-3p),0.651(miR-129-2-3p)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Gastric Juice",
    "sample": "141 gastric juices samples from gastric cancer, gastric ulcer, atrophic gastritis, and minimal gastritis patients or subjects with normal mucosa",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23307240"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Predictor for prognosis (hazard ratio (HR) = 4.51; P=0.0096) and tumor recurrence",
    "expression": "Upregulated",
    "significance": "AUC=0.718 (Adenoma v/s normal), AUC=0.830 (CRC patient v/s normal)",
    "sample_type": "Tissue",
    "sample": "179 primary CRC tissues, serum samples of 211 CRCs, 56 adenomas and 57 control subjects.",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "miRNA array",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27502702"
  },
  {
    "miRNA_name": "miR-1292",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "Cell line and tissues",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-1294",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had poorer prognosis(p=0.040)",
    "expression": "Downregulated",
    "significance": "p=0.014",
    "sample_type": "Tissue",
    "sample": "79 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925090"
  },
  {
    "miRNA_name": "miR-1297",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : serum miR-1297 was an ideal diagnostic marker of ESCC,AUC on serum miR-1297 was 0.840+-0.035 in discovery grp and 0.837+-0.034 in validation grp",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Serum",
    "sample": "156  pair of ESCC & healthy serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27152453"
  },
  {
    "miRNA_name": "miR-129b",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Serum",
    "sample": "Serum,  55 patients with CRC and 55 control subjects",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318304"
  },
  {
    "miRNA_name": "miR-129b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Serum",
    "sample": "Serum,  55 patients with CRC and 55 control subjects",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318304"
  },
  {
    "miRNA_name": "miR-130a",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic :AUC =0.905(tissues expression) & AUC=0.870(serum expression)",
    "expression": "Upregulated",
    "significance": "p=0.018(tissues),p=0.0041(serum),p=0.021(cell lines)",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "SGC7901,HGC27,AGS,MKN45,N87,GES-1,41 GC & adjacent normal tissues,41 GC & 41 healthy serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26134263"
  },
  {
    "miRNA_name": "miR-130a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low tissues expression had improved OS",
    "expression": "Upregulated",
    "significance": "p=0.018(tissues),p=0.0041(serum),p=0.021(cell lines)",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "SGC7901,HGC27,AGS,MKN45,N87,GES-1,41 GC & adjacent normal tissues,41 GC & 41 healthy serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26134263"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "The 5-year survival rate of the miR-132 high-expression group was significantly better than that of the low-expression group (p < 0.01)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "201 paired GC and matched adjacent normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28918037"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Downregulatedregulation-poor prognosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues (Surgical specimens of cancer tissues and adjacent nontumor tissue from 36 patients)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26675712"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "prognosis",
    "expression": "Downregulated",
    "significance": "p=0.040 (over all survival), p=0.015(disease free survival)",
    "sample_type": "Tissue",
    "sample": "Tissue samples from 151 patients [135 primary lesions (109 without liver metastasis and 26 with liver metastasis), and 16 liver metastatic lesions arising from CRC]",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26868958"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "expression": "Downregulated",
    "significance": "Overall survival p = 0.040, disease-free survival p = 0.015",
    "sample_type": "Tissue",
    "sample": "Tissue samples from 151 patients [135 primary lesions (109 without liver metastasis and 26 with liver metastasis), and 16 liver metastatic lesions arising from CRC].",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26868958"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Potential diagnostic marker",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26324336"
  },
  {
    "miRNA_name": "miR-1322",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-serum marker miR-1322 (AUC-0.847)",
    "expression": "Upregulated",
    "significance": "p<0.01(serum & tissues)",
    "sample_type": "Serum Tissue",
    "sample": "Serum,tissue",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22315007"
  },
  {
    "miRNA_name": "miR-133",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: overall survival rate of high expression group was higher than low expression(P=0.003)",
    "expression": "Downregulated",
    "significance": "p<0.01(gc tissues)",
    "sample_type": "Tissue Cell-line",
    "sample": "180 pairs of GC tissues,AGS,BGC823,MGC803,SGC7901,MKN-45,MKN-1,GES-1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25152372"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC=0.907",
    "expression": "Downregulated",
    "significance": "AUC=0.907, p<0.05",
    "sample_type": "Gastric Juice",
    "sample": "204 gastric juices",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27268657"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlated with poorer overall survival (OS)",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "Tumor samples and adjacent non-cancerous tissues from 169 patients undergoing radical resection for CRC",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25170220"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "100 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Patients with a higher expression of miR-133a had a significantly lower overall survival",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "125 resected CRC tissues",
    "continent": "Asia",
    "population": "Hong Kong",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25104873"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "expression": "Upregulated",
    "significance": "p=0.0002",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-133a-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early Diagnosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues.",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RNA deep sequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "100 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker",
    "expression": "Downregulated",
    "significance": "AUC=0.857 (p<0.0001), with 78.9% sensitivity and 81.6% specificity",
    "sample_type": "Tissue",
    "sample": "38 CRC and corresponding non-cancerous tissues (NCTs)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RT-qPCR, in situ hybridization (ISH)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28098895"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor survival",
    "expression": "Downregulated",
    "significance": "p=0.028",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 50 CRC patients",
    "continent": "Europe",
    "population": "Sweden",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21573504"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with lower survival",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "27 primary and liver metastasis tumors",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qPCR arrays",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25075017"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Predictor of poor survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues ( 168 pairs of CRC specimens and adjacent noncancerous tissues) and cell line",
    "continent": "N/A",
    "population": "N/A",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26897940"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Could discriminate non-LNM from LNM with 50.0% sensitivity and 100.0% specificity at the best cut-off value of 0.0901 and discriminate tumor Ι-II stages from tumor III-IV stages with 37.5% sensitivity and 100.0% specificity at the best cut-off value of 0.1122",
    "expression": "Downregulated",
    "significance": "p=0.034",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive stool marker for CRC and Adenoma patients",
    "expression": "Upregulated",
    "significance": "p=0.0001",
    "sample_type": "Stool Tissue",
    "sample": "40 pairs of CRC tissues, 16 pairs of advanced adenoma tissues, and 424 stool samples, including 104 CRCs and 109 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24691020"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "An evidence against usage of serum miR-17-3p, miR-29a, miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "expression": "No Significant Difference",
    "significance": "p>0.05",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Rectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Expression correlated significantly with disease-free and cancer-specific survival",
    "expression": "Upregulated",
    "significance": "p=0.0000000000283",
    "sample_type": "Tissue",
    "sample": "Multicenter cohort of 116 patients, Tumor biopsies",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "microarray and qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22850566"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "",
    "continent": "South America",
    "population": "Brazil",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26877610"
  },
  {
    "miRNA_name": "miR-135b-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RNA deep sequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-136",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low expression associated with worse Prognosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Cell-line",
    "sample": "GC peritoneal metastatic parental sublines : GC-9811,GC-9811P,GC-9811P1,GC-9811P2,GC-9811P3",
    "continent": "Cell-line",
    "population": "Cell-line",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28656883"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: to identify ptients with lymph node metastasis",
    "expression": "Upregulated",
    "significance": "Fold Change=6.6-folds, p=0.036",
    "sample_type": "Tissue",
    "sample": "Colonic tissues derived from stage II-III colon cancer patients with (n = 3) and without (n = 3) lymph node metastasis. Lymph node positive vs. Lymph node negative.",
    "continent": "Asia",
    "population": "China",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19659786"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for GC except for TNM stage",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "154 GAC tissues after radical gastrectomy",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26545111"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "18 paired GC & surgical margin tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27468717"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic market for early diagnosis",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "409 colorectal tissues [21 normal colonic mucosa from healthy individuals (N-N), 160 primary CRC tissues and their corresponding normal mucosa (N-C), and 68 adenomas].",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR and and in situ hybridization",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20682795"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had shorter survival(p<0.001)",
    "expression": "Downregulated",
    "significance": "p<0.05(cell lines)",
    "sample_type": "Tissue Cell-line",
    "sample": "205 archived ESCC,20 paired tissues,NEEC1,NEEC2,KYSE30,KYSE510,ECA109,HKESC1,KYSE180,KYSE410,KYSE140,E18,KYSE520",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCr",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23319823"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum/ tissue low level",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Serum",
    "sample": "168 serum,128 ESCC and corresponding normal",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28759955"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-138-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall survival",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "188 CRC samples, Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27248318"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall survival",
    "expression": "Upregulated",
    "significance": "p=0.025",
    "sample_type": "Tissue",
    "sample": "63 pairs of colon cancer and adjacent non-cancerous tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25550849"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "To distinguish Stage IV CRC from controls",
    "expression": "N/A",
    "significance": "AUC=0.896, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RNA deep sequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Thirty six pairs of CRC tissues and matched adjacent normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26402430"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor OS",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "99 mCRC patients, out of 99 33 patients had wild-type KRAS/BRAF and third- to sixth-line anti-EGFRmAb treatment",
    "continent": "Europe",
    "population": "Finland",
    "detection_method": "Microarray and qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23098991"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor : lymph node metastasis(p=0.003),distant metastasis(p=0.001),TNM(p<0.001) & miR-141  expression",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "95 paired tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26681225"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "GC specimens, SGC-7901",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker for metastatic colon cancer.",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "102 plasma samples collected from USA. independent cohort of 156 plasma samples collected from China",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21445232"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Predicts poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "102 plasma samples collected from USA. independent cohort of 156 plasma samples collected from China",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21445232"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Differentiated stage IV CRC from stage I-III patients",
    "expression": "Upregulated",
    "significance": "AUC=0.851",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 187 CRC cases and 47 healthy controls",
    "continent": "USA",
    "population": "USA",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "continent": "Cell-line",
    "population": "Cell-line",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic :plasma level( AUC=0.839)",
    "expression": "Downregulated",
    "significance": "p=0.002(tissues),p<0.001(plasma)",
    "sample_type": "Tissue Plasma",
    "sample": "51 paired tissues,80 GC & 80 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Downregulated",
    "significance": "p=0.002",
    "sample_type": "Plasma",
    "sample": "Pre-operative plasma from 61 recently diagnosed colorectal cancer patients (including 13 stage I, 41 stage II and 7 stage III patients) and 24 (age and gender-matched) healthy subjects",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26413249"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic- miR-142-3p expression :p=0.017(univariate),p=0.022(multivariate)",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "91 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21882196"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "expression": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls",
    "expression": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Frequently downregulated in the smaller adenomas",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression of miR-143 in GC associated with worse cancer specific mortality(p=0.0141)",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "15 schirrous type GC & 5 non scirrous type GC tissues,30 FFPE schirrous & non schirrous type GC GC,FFPE",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24283360"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "The combined expression of miR-143 and miR-145 was significantly associated with the risk for esophageal cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "110 EC Tissues and Normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22457808"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "marker": "Prodnostic",
    "marker_details": "The combined expression of miR-143 and miR-145 was significantly associated with the risk for esophageal cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "110 EC Tissues and Normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22457808"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Progression free survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "820 patients with advanced CRC, primary tumors and matched normal tissue",
    "continent": "Europe",
    "population": "CAIRO study (ClinTrials.gov NCT00312000) of the Dutch Colorectal Cancer Group",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26392389"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Patients with a higher expression of miR-143 had disease-free interval",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "46 patients with CRC, Paired tissues",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20620599"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator- low levels of miRNA-143 expression is an independent prognostic factor with respect to cancer specific survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "77 CRC patients who were identified by pyrosequencing to have wild-type KRAS and were subsequently treated with EGFR-targeted therapy with the monoclonal antibodies cetuximab or panitumumab.",
    "continent": "Europe",
    "population": "Austria",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22549179"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-143-3p expression had a poorer OS than those with high expression",
    "expression": "Downregulated",
    "significance": "p<0.01(tissues,KYSE-30,KYSE-70,ECA109)",
    "sample_type": "Tissue Cell-line",
    "sample": "80 pairs of primary ESCC 7 adjacent normal tissues,HEEC,KYSE30,KYSE70,ECA109,EC9706",
    "continent": "Asia",
    "population": "China",
    "detection_method": "microarray, qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27358073"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-high H.pylori infection",
    "expression": "Downregulated",
    "significance": "p<0.001(tissues & cell lines)",
    "sample_type": "Tissue Cell-line",
    "sample": "GC &  normal tissues(42 each),GEs1,SGC7901,HGc27,MGC803,Ags,MKN45,BGC823",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404925"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-high H.pylori infection",
    "expression": "Upregulated",
    "significance": "p<0.001(tissues & cell lines)",
    "sample_type": "Tissue",
    "sample": "H.pylori positive & negative GC(42)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404925"
  },
  {
    "miRNA_name": "miR-143-5p",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker: high-risk groupregulated had significantly shorter disease-free survival",
    "expression": "N/A",
    "significance": "p=0.023",
    "sample_type": "Tissue",
    "sample": "Tumor samples from 71 white patients with stage II colon cancer",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "--",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247088"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Saliva Plasma",
    "sample": "Saliva",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24369245"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- serum level in EC",
    "expression": "Upregulated",
    "significance": "p=0.010(tissues),p=0.015(serum)",
    "sample_type": "Tissue Serum",
    "sample": "19 EC & 19 normal serum,12 pre neoplastic, 35 neoplastic & matched distant non neoplastic tissues",
    "continent": "Asia",
    "population": "India",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27748283"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Blood",
    "sample": "Tissues and peripheral blood samples from 96 gastric cancer patients",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28800316"
  },
  {
    "miRNA_name": "miR-144*",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker for CRC detection",
    "expression": "Upregulated",
    "significance": "Sensitivity of 74% and a specificity of 87% (n=75, p < 0.0001)",
    "sample_type": "Stool",
    "sample": "75 Fecal specimens were collected from patients who underwent colonoscopy",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21863218"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-miR-145 AUC:0.74",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "40 FFPE",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773691"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Frequently downregulated in the smaller adenomas",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "The combined expression of miR-143 and miR-145 was significantly associated with the risk for esophageal cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "110 EC Tissues and Normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22457808"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "marker": "Prodnostic",
    "marker_details": "The combined expression of miR-143 and miR-145 was significantly associated with the risk for esophageal cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "110 EC Tissues and Normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22457808"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Marker for EMT",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "45 CRC tisues",
    "continent": "Eurasia",
    "population": "Russia",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "expression": "Upregulated",
    "significance": "p=0.0004",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "expression": "Upregulated",
    "significance": "p≤0.005",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "continent": "USA",
    "population": "USA",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic indicator for OS (p = 0.011).",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "145 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27460730"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-1469",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-1469 expression had significant poorer disease free survival(p=0.004) and OS(p=0.029)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "",
    "sample": "129 patients",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28588716"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "miR-146a expression level is an ideal diagnostic biomarker of ESCC",
    "expression": "Downregulated",
    "significance": "p<0.001(tissues,serum)",
    "sample_type": "Tissue Serum",
    "sample": "62 pairs of ESCC & adjacent paracancerous tissues,115 FFPE,154 ESCC & 154 healthy serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26794279"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "miR-146a expression level is an ideal prognostic marker of ESCC",
    "expression": "Downregulated",
    "significance": "p<0.001(tissues,serum)",
    "sample_type": "Tissue Serum",
    "sample": "62 pairs of ESCC & adjacent paracancerous tissues,115 FFPE,154 ESCC & 154 healthy serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26794279"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low expression of miR-146a was associated with poor prognosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "43 colonic cancer tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24670457"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : OS time with higher miR-146a expression was longer than low expression(p=0.011)",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Cell-line",
    "sample": "43 patients tissues,cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21347720"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-148",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high miR-148 expression have shorter DFS(p=0.0145)  & shorter OS (P=0.0016) in EAC, low miR-148 level have shorter OS(p=0.0014) in ESCC",
    "expression": "Upregulated",
    "significance": "p=0.0014(miR-148 in EAC vs ESCC)",
    "sample_type": "Tissue",
    "sample": "62 tissues ( ESCC,EAC,normal epitehlial mucosa)",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker for CDDP resistance in GC",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "TCGA Dataset,GEO Dataset,Tissue,Cell-line",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "continent": "N/A",
    "population": "N/A",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.842)",
    "expression": "Downregulated",
    "significance": "p<0.001(tissues),p<0.001(plasma)",
    "sample_type": "Tissue Plasma",
    "sample": "52 paired tissues,80 GC & 80 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- miRNAs are potential biomarker for GC",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "35 GC & 33 normal samples",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24527072"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Prognostic : lower miR-148 exps. Had worse prognosis(log-rank test,p<0.0001)",
    "expression": "Downregulated",
    "significance": "p<0.001(gc vs non neoplastic tissues in n=61",
    "sample_type": "Tissue Cell-line",
    "sample": "20 GC & 5 non neoplastic tissues & 61 pair  tissues,MKN1,HCS-45",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24283384"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic classifier in patients with stage III CRC",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Colorectal adenoma (n = 21) and CRC (stage I-IV, n = 159), formalin-fixed paraffin-embedded tissue samples",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26389729"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Lower levels associated with significantly shorter disease-free survival rates and poorer overall survival rates.",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Serum",
    "sample": "Tissues and Serum from 55 early relapsed patients and 55 nonearly relapsed patients, stage II stage and III colorectal cancer",
    "continent": "Asia",
    "population": "Taiwan",
    "detection_method": "Microarray followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23933284"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic - Higher expression associated with decreased progression-free survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "continent": "Europe",
    "population": "Norway",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor OS",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "FFPE tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27529338"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Associated with poor prognosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "78 cases of CRC tissues,",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25613903"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-149 was associated with lower 5-year survival rate, an independent prognostic factor for overall survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "CRC Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "bisulphite sequencing PCR and methylation-specific PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22821729"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "TaqMan MicroRNA assays",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had low miR-150 expression had shorter survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR and In-situ Hybridization",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-poor prognosis for low expression(univariate analysis)",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "108 paired curative surgical tissues",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRt-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23013135"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguished groups of patients with polyps from those with advanced cancer",
    "expression": "Downregulated",
    "significance": "Plasma (FC = -1.29, p-value = 0.013) and cancer tissue (FC = -2.55, p-value = 4.104e-08)",
    "sample_type": "Tissue Plasma",
    "sample": "Tissue, Plasma, 97 subjects",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25924769"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic Indicator, Sensitivity of 80% and specificity of 74% (p<0.0001)",
    "expression": "Downregulated",
    "significance": "Sensitivity of 80% and specificity of 74% (p<0.0001)",
    "sample_type": "Blood",
    "sample": "Peripheral blood of 71 patients and 80 matched healthy controls",
    "continent": "Europe",
    "population": "Slovak Republic",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798914"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "202 colorectal cancer and adjacent colorectal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27784461"
  },
  {
    "miRNA_name": "miR-153",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis,5 year overall and disease free survival",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "80 GC & adjacent non tumor tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25678802"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival (P = 0.006)",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "Tissue, 169 pairs of CRC specimens and adjacent noncancerous tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26048406"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Low plasma miR-155 level as Diagnostic marker",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22891887"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Re-elevation associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Predictive biomarkers for POCD",
    "expression": "Upregulated",
    "significance": "p=0.002",
    "sample_type": "Tissue",
    "sample": "110 POCD patients",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27872469"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "The overall and disease-free survival rates of patients with high miR-155 expression were significantly worse than those of patients with low miR-155 expression",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "156 CRC patients, Tissues",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21412018"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - serum level",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue Serum",
    "sample": "Tissues, serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27802201"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic- serum level",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue Serum",
    "sample": "Tissues, serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27802201"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls, To distinguish Stage IV CRC from controls",
    "expression": "N/A",
    "significance": "AUC=0.896, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls, To distinguish Stage IV CRC from controls",
    "expression": "N/A",
    "significance": "AUC=0.896, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Low-miR-16 had lower 5-year overall survival than those with high-miR-16",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "143 primary CRC tissues and 18 corresponding normal colonic mucosa from patients who had undergone surgery",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24045965"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-16 (HR 2.26; 95 % CI 1.51-3.40; P < 0.001) predicted shorter OS, while tumor status (HR 1.59; 95 % CI 0.73-3.48 P = 0.242), lymph node metastasis (HR 1.41; 95 % CI 0.71-2.82; P = 0.326) and tumor size (HR 1.53; 95 % CI 0.92-2.55; P = 0.099) were not.according to multivariate",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "180 GC patient after surgery for microarray preparation,paracancerous normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "tissue microaaray,miRNA-locked nucleic acid ISH",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27605261"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Predicts poor disease-free survival (DFS) and overall survival (OS)",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "182 colorectal adenocarcinoma specimens and 86 non-cancerous colorectal mucosae",
    "continent": "Europe",
    "population": "Greece",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27930363"
  },
  {
    "miRNA_name": "miR-16-5p",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "miRNA microarray profiling,qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25897338"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.879 with 80.6% sensitivity and 87.5% specificity for discriminating GC patients from controls , AUC of 0.717 with 90.6% sensitivity and 57.5% specificity for discriminating GC patients from BGD patients and  AUC of 0.725 with 62.9% sensitivity and 81.2% specificity for discriminating BGD patients from controls",
    "expression": "Downregulated",
    "significance": "p=0.000(Gc vs healthy),p=0.002(BGD vs healthy),p=0.001(Gc vs BGD)",
    "sample_type": "Serum",
    "sample": "40 GC,32 benign gastric disease(BGD) & 36 healthy sera",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561770"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "expression": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with a higher risk of disease progression and risk of death",
    "expression": "Upregulated",
    "significance": "p=0.003",
    "sample_type": "Tissue",
    "sample": "38 patients with colorectal, gastric or pancreatic cancer, FFPE Tumours",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21743960"
  },
  {
    "miRNA_name": "miR-17-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Upregulated",
    "significance": "p<0.0005",
    "sample_type": "Plasma",
    "sample": "Plasma of 25 patients with CRC and 20 healthy controls.",
    "continent": "Asia",
    "population": "China",
    "detection_method": "MicroRNA profiling and qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19201770"
  },
  {
    "miRNA_name": "miR-17-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "An evidence against usage of serum miR-17-3p, miR-29a, miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "expression": "No Significant Difference",
    "significance": "p>0.05",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Prognostic: expression not associated wth patients OS",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Cell-line",
    "sample": "28 patients GC & adjacent  normal  tissues,SNU-601,SNU-668,AGS,MKN-28, HeLa",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24801601"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "In late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "295 patients, who underwent tumor resection",
    "continent": "Asia",
    "population": "China",
    "detection_method": "Microarray and qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "FFPE specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RNA deep sequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-17-92 cluster",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Patients expressing high levels of miR-17 showed reduced overall survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "48 colon tumor and 48 paired normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22065543"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "High expression group had a significantly poorer prognosis than the low expression group",
    "expression": "No Significant Difference",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "162 CRC patients who underwent resection of primary CRC",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23023298"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic for OS and recurrence free survival",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Cell-line",
    "sample": "105 tissues,HEEc,KYSe150,KYSE410,OE19,ECA109,EC9706",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25230784"
  },
  {
    "miRNA_name": "mir-181a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "CRC tissue and non-cancer liver tissue were obtained from patients with colorectal cancer. 72 CRC patients and 69 normal (control) patients for survival analysis.",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26750720"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low miR-181a expression was associated with poor progression free survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "80 patients with wild type KRAS CRC undergoing treatment with the EGFR-targeting monoclonal antibodies cetuximab and panitumumab for metastatic CRC",
    "continent": "Europe",
    "population": "Austria",
    "detection_method": "qRT-PCR and Pyrosequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24098024"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "expression": "Upregulated",
    "significance": "p≤0.005",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "continent": "USA",
    "population": "USA",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker only for Black patients",
    "expression": "Upregulated",
    "significance": "p=0.004",
    "sample_type": "Tissue",
    "sample": "Tissues collected from 106 black and 239 white patients",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23719259"
  },
  {
    "miRNA_name": "miR-181c-3p",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high expression of miR-181c-3p  associated with poor prognosis(p<0.05)",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "55 pairs of ESCC & adjacent non neoplastic tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "microarray,qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26888510"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "138 CRC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "in-situ Hybridization",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25031782"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "High miR-182 expression predicted poor survival",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "148 pairs of colorectal cancer and adjacent noncancerous tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23474644"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "expression": "Upregulated",
    "significance": "Fold Change=3.2, p=0.008",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 51 CRC patients and controls",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25115394"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : predicts poor overall survival (p=0.007)",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "116 malignant colorectal adenocarcinoma specimens and 60 paired non-cancerous tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24615484"
  },
  {
    "miRNA_name": "miR-182-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RNA deep sequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low expression is associated with poor prognosis(p=0.008)",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Cell-line",
    "sample": "52 pairs of paraffin embedded GC & adjacent  normal tissues,MGC-803,SGC-7901,BGC823,MKN45,MKN28,GES-1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25337200"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : shorter survival in low expression grp(p<0.05)",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "Stage II tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22851079"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-183 had lower survival rate(P=0.020)",
    "expression": "Downregulated",
    "significance": "p<0.05(gc cell lines), p<0.001(gc tissues)",
    "sample_type": "Tissue Cell-line",
    "sample": "65 GC & matched adjacent normal tissues,GES-1,MGC-803,MKN28,SGC7901,AGS,HGC27",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25295122"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter disease-free survival (DFS) and lower overall survival (OS)",
    "expression": "Upregulated",
    "significance": "AUC=0.829",
    "sample_type": "Plasma Tissue Cell-line",
    "sample": "Plasma from 118 CRC patients and 61 healthy , CRC tissues and CRC cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25629978"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma miR-185;AUC was 0.73(95% CI  0.604-0.855)",
    "expression": "Downregulated",
    "significance": "p=0.002",
    "sample_type": "Plasma",
    "sample": "28 ESCC and 35 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26316588"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Prognostic : low miR-185 level correlates with shorter survival(p<0.0001)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, GES-1,SGC7901,BGC823,MKN28,MGC803,HGC27,AGS,MKN45",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24352663"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor survival",
    "expression": "Upregulated",
    "significance": "p=0.001",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 50 CRC patients",
    "continent": "Europe",
    "population": "Sweden",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21573504"
  },
  {
    "miRNA_name": "miR-188-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "expression": "N/A",
    "significance": "HR=1.538; p = 0.010",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive marker for detection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "40 pairs of CRC tissues and 595 stool samples (198 CRCs, 199 polyps and 198 normal controls)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "array followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25233396"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "ISH",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26173586"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "miR-18a overexpression group had a poorer clinical prognosis than the low expression group (P=0.07)",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: serum miR-191 is a potential GC diagnostic marker(ROC=0.0849,95%CI:0.78-0.92)",
    "expression": "Upregulated",
    "significance": "p<0.01(miR-191 in serum & tissue)",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "75 GC & adjacent normal tissues,57 GC & 58 healthy serum,HGC27,MGC803,MKN45,SGC7901",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC for plasma miR-192=0.732(95%CI,0.625-0.841,p<0.01)",
    "expression": "Upregulated",
    "significance": "p<0.01( GC/DM vs GC/NDM & Hc group  plasma)",
    "sample_type": "Plasma",
    "sample": "GC,DM,NDM plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481716"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Plasma miR-192 level not associated with OS  in GC",
    "expression": "Upregulated",
    "significance": "p<0.01( GC/DM vs GC/NDM & Hc group  plasma)",
    "sample_type": "Plasma",
    "sample": "GC,DM,NDM plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481716"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-192-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-192-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-193a-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Downregulated regulation associated with poorer survival",
    "expression": "Downregulated",
    "significance": "p=0.0060",
    "sample_type": "Tissue",
    "sample": "304 formalin-fixed, paraffin-embedded specimens",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25232258"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high fold change of down regulated miR-193b had significant shorter survival time compared to low fold change of down regulated miR-193b",
    "expression": "Downregulated",
    "significance": "p=0.000",
    "sample_type": "Tissue",
    "sample": "48 pairs of GC & matched ANTTs  tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25374225"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC-0.512,plasma miR-194 level is not a biomarker for DGC",
    "expression": "No Significant Difference",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Diffuse type gastric cancer(DGC), plasma-50 DGC and healthy cobtrol",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27909811"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Serum",
    "sample": "Serum,  55 patients with CRC and 55 control subjects",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318304"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Serum",
    "sample": "Serum,  55 patients with CRC and 55 control subjects",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318304"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter survival",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "20 normal colorectal mucosa cases, 40 colorectal adenomas cases and 40 CRC cases",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25285168"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for colorectal liver metastasis",
    "expression": "Upregulated",
    "significance": "Fold Change=6.5, p = 0.0001",
    "sample_type": "Tissue",
    "sample": "30 patients",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "Microaray and qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21722265"
  },
  {
    "miRNA_name": "miR-194-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-194-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.765)",
    "expression": "Downregulated",
    "significance": "p=0.003(tissues),p<0.001(plasma)",
    "sample_type": "Tissue Plasma",
    "sample": "53 paired tissues,80 GC & 80 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "98 pairs tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25400770"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "expression": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colorectal Cancer",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls",
    "expression": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlates with poor prognosis  reduced expression of miR-195 was an independent predictor of overall survival.",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "Two colorectal cancer cell lines and 85 colorectal cancer and paired normal patient samples",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21390519"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- both miRNAs are potential biomarker for GC",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "35 GC & 33 normal samples",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24527072"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Upregulated",
    "significance": "p=0.002(tissues)",
    "sample_type": "Tissue Saliva",
    "sample": "Tissues, saliva",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28095062"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Circulating miR-196a exhibited higher diagnostic capacity than combined miR-196a/b or miR-196b alone",
    "expression": "Upregulated",
    "significance": "p<0.001(gc vs healthy plasma),p=0.004(preoperative vs postoperative plasma)",
    "sample_type": "Plasma",
    "sample": "98 GC & 126 healthy plasma,",
    "continent": "Asia",
    "population": "Taiwan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420607"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher miR-196a expression was correlated with shorter OS",
    "expression": "Upregulated",
    "significance": "p<0.01(tissue and cll lines)",
    "sample_type": "Tissue Cell-line",
    "sample": "36 GC & adjacent normal tissues,MGC803,MKN-28,SGC7901,GES-1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22343731"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: overall survival time for low fold change of upregulated miR-196a was significantly lower than that with high fold change of upregulated miR-196a",
    "expression": "Upregulated",
    "significance": "p=0.000",
    "sample_type": "Tissue",
    "sample": "48 pairs of GC & matched ANTTs tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25374225"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: upregulation of miR-196a have poorer 5 year survival",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "109 GC tissues",
    "continent": "Asia",
    "population": "Taiwan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24933454"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Upregulated",
    "significance": "p<0.001(gc vs healthy plasma)",
    "sample_type": "Plasma",
    "sample": "98 GC & 126 healthy plasma,",
    "continent": "Asia",
    "population": "Taiwan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420608"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Upregulated",
    "significance": "p<0.001(gc vs healthy plasma)",
    "sample_type": "Plasma",
    "sample": "98 GC & 126 healthy plasma,",
    "continent": "Asia",
    "population": "Taiwan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420608"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Prognostic: poor prognosis(p<0.001)",
    "expression": "Upregulated",
    "significance": "p=0.007",
    "sample_type": "Tissue",
    "sample": "12 pairs of & non cancer tissues",
    "continent": "Asia",
    "population": "South Korea",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24222951"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: upregulation of miR-196b have poorer 5 year survival",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "109 GC tissues",
    "continent": "Asia",
    "population": "Taiwan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24933454"
  },
  {
    "miRNA_name": "miR-196b-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Biomarkers for prediction of the efficacy of vaccine treatment for patients with metastatic CRC",
    "expression": "Upregulated",
    "significance": "p=0.002",
    "sample_type": "Tissue",
    "sample": "Phase I study (UMIN clinical trial registration no. UMIN000004948) and phase II trial, 16 patients, Treatment eith HLA-A*2402 restricted peptides peptide cocktail and oxaliplatin-based chemotherapy",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "Microarray",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28789351"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Upregulated",
    "significance": "p=0.043",
    "sample_type": "Tissue",
    "sample": "46 EC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25117314"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "prognosis-poor survival(p<0.001) in low expression group",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "106 paired GC & adjacent non tumor tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26852230"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "expression": "Upregulated",
    "significance": "p<0.05 ( poor vs good prognosis samples)",
    "sample_type": "Tissue",
    "sample": "46 surgical tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24175778"
  },
  {
    "miRNA_name": "miR-1995p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with long overall survival (p=0.01)",
    "expression": "Upregulated",
    "significance": "Higher in primary tumors than in matched liver metastases (p=0.007), high in stage III patient without metastasis (p=0.028)",
    "sample_type": "Tissue",
    "sample": "56 pairs of primary CRC samples and their corresponding liver metastasis tissues (8 pairs of fresh frozen and 48 pairs of paraffin-embedded specimens)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26259252"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential diagnostic marker,ROC- 0.837 with 80% sensitivity and 74% specificity",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Plasma",
    "sample": "210 GC & 110 healthy plasma(qRT-PCR)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "microarray, qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22956063"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential diagnostic marker(AUC=0.818,sensitivity=76%,specificity=74%,accuracy=75%)",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma",
    "sample": "80 GC post & pre operative plasma & 70 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23733518"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic facctor for survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 colorectal cancer cases",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292866"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-199b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with longer median survival",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "30 pairs of CRC metastatis tissues and primary CRC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27145368"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: independent prognostic factor associated with OS",
    "expression": "Upregulated",
    "significance": "p≤0.01",
    "sample_type": "Tissue",
    "sample": "15 & adjacent normal  tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24675462"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for colorectal liver metastasis",
    "expression": "Upregulated",
    "significance": "Fold Change=7.7 at the tumor invasion front (p = 0.0001)",
    "sample_type": "Tissue",
    "sample": "30 patients",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "Microaray and qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21722265"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572553"
  },
  {
    "miRNA_name": "miR-19b-5p",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "miRNA microarray profiling,qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25897338"
  },
  {
    "miRNA_name": "miR-20",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnosis: screening",
    "expression": "Upregulated",
    "significance": "Tissues p=0.0065, faecal<0.0001, AUC=0.83",
    "sample_type": "Tissue Stool",
    "sample": "Tissues, faecal; Forty pairs of primary CRC and its adjacent normal tissues and Faecal samples from 595 subjects (198 CRCs, 199 adenomas, and 198 neoplasm-free controls).",
    "continent": "Asia",
    "population": "Hong Kong",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26621842"
  },
  {
    "miRNA_name": "miR-20",
    "cancer": "Colorectal Cancer",
    "marker": "Screening",
    "marker_details": "Diagnosis: screening",
    "expression": "Upregulated",
    "significance": "Tissues p=0.0065, faecal<0.0001, AUC=0.83",
    "sample_type": "Tissue Stool",
    "sample": "Tissues, faecal; Forty pairs of primary CRC and its adjacent normal tissues and Faecal samples from 595 subjects (198 CRCs, 199 adenomas, and 198 neoplasm-free controls).",
    "continent": "Asia",
    "population": "Hong Kong",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26621842"
  },
  {
    "miRNA_name": "miR-200",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Low miR-200 expression in colorectal liver metastases was associated with bad prognosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "60 FFPE  primary colorectal tumors, normal colon mucosa, and matched liver metastases",
    "continent": "Europe",
    "population": "Sweden",
    "detection_method": "in situ hybridization and qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24376848"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostric",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p=0.001",
    "sample_type": "Tissue",
    "sample": "88 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker - low miR-200a expression was associated with poor survival",
    "expression": "N/A",
    "significance": "p<0.05",
    "sample_type": "TCGA Dataset",
    "sample": "Cohort of 111 patients and 217 patients of the Cancer Genome Atlas data set",
    "continent": "Europe",
    "population": "Austria",
    "detection_method": "microarray followed by in-situ hybridization",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24504363"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "TaqMan MicroRNA assays",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200a-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200a-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RNA deep sequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-200b/c correlate with short survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "36 pairs of Gc & matched adjacent tissues,GES1,MGC803,BGC823,MKN28,SGC7901,HGC27,AGS,MKN45",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23995857"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p=0.003",
    "sample_type": "Tissue Cell-line",
    "sample": "88 tissues,7 cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguished stage I-IV CRC from healthy controls",
    "expression": "Upregulated",
    "significance": "AUC=0.74",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV), 187 CRC cases and 47 healthy controls",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-200b-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200b-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-200b/c correlate with short survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "36 pairs of Gc & matched adjacent tissues,GES1,MGC803,BGC823,MKN28,SGC7901,HGC27,AGS,MKN45",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23995857"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "GC specimens, SGC-7901",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum levelof miR-200c",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Serum",
    "sample": "Serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26662382"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Re-elevation associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker for CRC",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Serum",
    "sample": "3-phase study using FFPE tissue and serum from 446 colorectal specimens,",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23982750"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "expression": "Upregulated",
    "significance": "p=0.0196",
    "sample_type": "Tissue",
    "sample": "Chemotherapy surgical tissues",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "",
    "expression": "Upregulated",
    "significance": "p=0.017",
    "sample_type": "Serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "continent": "Cell-line",
    "population": "Cell-line",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC-ROC was 0.715(p=0.012),sensitivity=65.4%,specificity=100%,accuracy rate=73.1%",
    "expression": "Upregulated",
    "significance": "p=0.018(blood)",
    "sample_type": "Blood",
    "sample": "52 patients & 15 healthy blood",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22954417"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : Increased miR-200c level had poor OS(9 vs 24 months;p=0.016),PFS(4 vs 11 months;p=0.044)",
    "expression": "Upregulated",
    "significance": "p=0.018(blood)",
    "sample_type": "Blood",
    "sample": "52 patients & 15 healthy blood",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22954417"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Related to overall survival",
    "expression": "Upregulated",
    "significance": "For survival p<0.01",
    "sample_type": "TCGA Dataset",
    "sample": "255 CRC tumor samples from The Cancer Genome Atlas",
    "continent": "N/A",
    "population": "TCGA Data",
    "detection_method": "TCGA data",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28567416"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with patient survival (p = 0.0122).  The patients with higher  miR-200c expression had a shorter survival time",
    "expression": "Upregulated",
    "significance": "p=0.0017",
    "sample_type": "Tissue",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "TaqMan MicroRNA assays",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200c-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200c-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RNA deep sequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor survival",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "72 pairs of CRC tumor tissues and their corresponding adjacent non-tumor tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27376958"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognosis",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Serum",
    "sample": "130 GC & 22 healthy control serum",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26233325"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Serum",
    "sample": "130 GC & 22 control serum",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26233325"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-203 have shorter DFS in EAC (p=0.026)",
    "expression": "Downregulated",
    "significance": "p<0.0001(miR-203 in EAC vs control mucosa)",
    "sample_type": "Tissue",
    "sample": "62 tissues ( ESCC,EAC,normal epitehlial mucosa)",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Separated stage III-IV CRC patients from stage I-II",
    "expression": "Upregulated",
    "significance": "AUC=0.757",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV).",
    "continent": "USA",
    "population": "USA",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "expression": "Upregulated",
    "significance": "p≤0.005",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "continent": "USA",
    "population": "USA",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Predictor of short term survival",
    "expression": "Upregulated",
    "significance": "p=0.010",
    "sample_type": "Tissue Serum",
    "sample": "Short-term survivors compared to long-term survivors, Samples from 100 patients were used in the tumor cohort, and samples from an additional 50 patients were used in the serum cohort.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "next-generation sequencing followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27935861"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-203 was associated with poor survival of whites with stage IV colorectal cancers, but in blacks it was an indicator of poor survival of patients with stages I and II colorectal cancers",
    "expression": "Upregulated",
    "significance": "p=0.002",
    "sample_type": "Tissue",
    "sample": "Tissues collected from 106 black and 239 white patients",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23719259"
  },
  {
    "miRNA_name": "miR-203a",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-ESCC patients with reduced expression\nof miR-203a or hypermethylation of the miRNA\nshowed significantly poorer 5-year survival rates",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "119 ESCC & adjacent normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26577858"
  },
  {
    "miRNA_name": "miR-203a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic- stge III and stage IV low expression in GCA patients had poor survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27791400"
  },
  {
    "miRNA_name": "miR-203b",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-ESCC patients with reduced expression\nof miR-203b showed significantly poorer 5-year survival rates",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "119 ESCC & adjacent normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26577858"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.01( for gc vs normal & before treatment vs after treatment plasma)",
    "sample_type": "Plasma",
    "sample": "115 GC 7 40 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27173244"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: lower miR-204 had worst survival(p=0.017)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "84 gastric tumor & matched peritumoral tissues",
    "continent": "Europe",
    "population": "Rome and Italy",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23152059"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RNA deep sequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "272 paired colorectal cancer and Normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25294901"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC =0.85(95% CI:0.79-0.93;sensitivity=76%,specificity=84%",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma",
    "sample": "50 ESCC and 50 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26554762"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "expression": "Upregulated",
    "significance": "p<0.0001(tissues)",
    "sample_type": "Tissue Cell-line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : decreased level of miR-205 in tumor tissues correlates with poor OS in EAC",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "17 paired EAC & adjacent normal tissues & 22 ESCC ,22 EAC samples",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26711784"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:AUC=0.89,sensitivity=78%,specificity=86%",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Serum",
    "sample": "150 GC & 150 healthy serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27614739"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low serum level(OS & DFS both p<0.001), Recurrence vs non recurrence AUC=0.85",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Serum",
    "sample": "150 GC & 150 healthy serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27614739"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Independent Prognostic factor",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "220 self pair of GC & adjacent non-cancer tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25960238"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Shorter overall survival(p=0.02)",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "98 GC  & adjacent normal mucosa tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23751352"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Downregulation associated with poorer overall survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "CRC tissue compared to control tissue",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26406866"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic: miR-20a serum level",
    "expression": "Downregulated",
    "significance": "p<0.01( 55 paired pre-postoperative),p<0.05( 15 paired pre-postoperative serum)",
    "sample_type": "Serum",
    "sample": "Pre and post operative serum samples",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28413641"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent predictor of low survival rates",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "86 patients with primary CRC who underwent surgery without preoperative treatment",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24737193"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "expression": "Upregulated",
    "significance": "p=0.001",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "expression": "Upregulated",
    "significance": "p≤0.005",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "continent": "USA",
    "population": "USA",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with survival",
    "expression": "Upregulated",
    "significance": "For Survival p=0.024",
    "sample_type": "Tissue",
    "sample": "Tissues,  11 patients",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma expression( AUC =0.7944)",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma Tissue",
    "sample": "70 GC patients(43 Hp infection & 27 without) & 70 healthy(31 Hp infection & 39 without) plasma, 8 paired GC & adjacent normal tissues,",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- miR-21 saliva supernatant level: AUC-0.762,sensitivity-84.4%,specificity-62.5%",
    "expression": "Upregulated",
    "significance": "p=0.003",
    "sample_type": "Saliva Plasma",
    "sample": "32 EC and 16 healthy saliva supernatant",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23464420"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:  miR-21 AUC in serum=0.912,in PBMC=0.898",
    "expression": "Upregulated",
    "significance": "p<0.001 and miR-21 AUC in:serum=0.912, pBMCs=0.898",
    "sample_type": "Serum",
    "sample": "50 GC & healthy serum and PBMCs",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26063956"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC= 0.7944",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma",
    "sample": "60 GC & 60 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma miR-21:sensitivity-96%(stageI),64%(stage II),97%(stageI+IIEC) & specificity(44%,84%.56% respectively for stages), saliva miR-25 :sensitivity-90%,88%,89% respectively for stages and specificity 64% for all stages",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Saliva Plasma",
    "sample": "150 saliva,plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24968850"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC=80.3",
    "expression": "Upregulated",
    "significance": "p=0.012",
    "sample_type": "Tissue",
    "sample": "32 pateints for GC & paired adjacent normal gastric tissues",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26209976"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Upregulated",
    "significance": "p<0.001(ESCC serum vs healthy),p=0.003 (postoperative vs preoperative and responder)",
    "sample_type": "Serum",
    "sample": "Serum",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22354855"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - more significant markers in cancers than in adenomas",
    "expression": "Upregulated",
    "significance": "p=0.0289",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC=0.79",
    "expression": "Upregulated",
    "significance": "p<0.05(lymph node metastasis than non )",
    "sample_type": "Tissue",
    "sample": "GC patients tissues  without lymph node metastasis (n = 56), GC patients with lymph node metastasis (n = 30), and normal controls (n = 72)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22792096"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic/Screening marker",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "sample_type": "Stool",
    "sample": "Stool samples were collected from 88 patients with CRC, 57 patients with colorectal polyps and 101 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21930727"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "AUC=0.75,sensitivity=0.70,specificity=0.78",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "50 tumor & adjacent tumor tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26509997"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Overall survival rate with high miR-21 expression was lower than low expression (p<0.05)",
    "expression": "Upregulated",
    "significance": "p<0.05(lymph node metastasis than non )",
    "sample_type": "Tissue",
    "sample": "GC patients tissues  without lymph node metastasis (n = 56), GC patients with lymph node metastasis (n = 30), and normal controls (n = 72)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22792096"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "High miR-21 related with lower OS rate",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "50 tumor & adjacent tumor tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26509997"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with reduced progression-free survival (PFS) and overall survival",
    "expression": "Upregulated",
    "significance": "For pFS (p=0.0109) and OS (p=0.0675)",
    "sample_type": "Tissue",
    "sample": "32 patients who underwent primary tumor resection and received palliative chemotherapy for unresectable metastatic CC",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798874"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : high expression level of miR-21 had poor OS(HR2.15,95%CI 1.16-3.97)",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "Tissues, serum,Kyse170,Eca109",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker - high miR-21 expression was associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "p<.001",
    "sample_type": "Serum",
    "sample": "Serum samples from 186 CRC patients, 60 postoperative patients, 43 advanced adenoma patients, and 53 control subjects.  And tissues from  166 matched primary CRC tissues",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23704278"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Prognostic : prognostic factor(p=0.0133,HR=13.4(95% CI=1.72-104.4)",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "69 preoperative GC plasma",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267156"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor survival in both the stage II/III Japanese cohort",
    "expression": "Upregulated",
    "significance": "p=0.0008",
    "sample_type": "Tissue",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 156 patients were treated at Japanese",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic- serum miR-200c level",
    "expression": "Upregulated",
    "significance": "p=0.0030",
    "sample_type": "Serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prediction of recurrence and poor prognosis in CRC patients with TNM stage II, III, or IV",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma Tissue",
    "sample": "326 CRC patients, plasma exosomes, primary tumor tissues, and liver metastasis tissues",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "TaqMan miRNA assays",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28376502"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high miR-21 plasma level as prognostic indicator",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "50 preoperative plasma",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22519435"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter recurrence-free survival",
    "expression": "Upregulated",
    "significance": "p=0.019",
    "sample_type": "Tissue",
    "sample": "Tissue sections, 277 consecutive patients with T3-4a colorectal cancer treated with R0 surgical resection",
    "continent": "Asia",
    "population": "Korea",
    "detection_method": "in situ hybridization",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25609245"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognosis: patients with APC mutation/high miR-21 had poorer overall survival rates than those with APC mutation/low miR-21, APC wild-type/high miR-21 and APC wild-type/low miR-21",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues from 195 colorectal cancer patients",
    "continent": "Asia",
    "population": "Taiwan",
    "detection_method": "DNA sequencing and qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23773491"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Paired tumor and normal mucosa samples",
    "continent": "Asia",
    "population": "Taiwan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21099344"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Screening",
    "marker_details": "Diagnostic/Screening marker",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "sample_type": "Stool",
    "sample": "Stool samples were collected from 88 patients with CRC, 57 patients with colorectal polyps and 101 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21930727"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic- miR-21 independent prognostic factor in EAC for DSS but not in ESCC",
    "expression": "Upregulated",
    "significance": "HR 1.76 (95% CI 1.05-2.97",
    "sample_type": "Tissue",
    "sample": "195 FFPE of GEC(129 ESCC,61 EAC,5 stomach)",
    "continent": "Europe",
    "population": "Denmark",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26481465"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent predictor of survival: increase in miR-21 expression was associated with a 50% reduction in the risk of mortality",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Blood",
    "sample": "Blood samples were collected from 102 CRC patients undergoing surgery with curative intent.",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23970420"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "patients with a higher expression of miR-21 had disease-free interval",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "46 patients with CRC, Paired tissues",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20620599"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlated significantly with shorter disease-free survival",
    "expression": "Upregulated",
    "significance": "p=0.004",
    "sample_type": "Tissue",
    "sample": "130 stage II colon and 67 stage II rectal cancer specimens",
    "continent": "Europe",
    "population": "Denmark",
    "detection_method": "in situ hybridization",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21069438"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Patients expressing high levels of miR-21 had significantly inferior recurrence-free cancer-specific survival",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "764 patients diagnosed with stage II colon cancer, FFPE Tissues",
    "continent": "Europe",
    "population": "Denmark",
    "detection_method": "In situ hybridisation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23011541"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor survival in stage II German cohhort",
    "expression": "Upregulated",
    "significance": "p=0.047",
    "sample_type": "Tissue",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 145 patients were German",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter disease-free survival (DFS)",
    "expression": "Upregulated",
    "significance": "p=0.014",
    "sample_type": "Tissue",
    "sample": "Tumor tissue, paired normal tissue, Mesenteric Vein blood and Peripheral Vein blood of 57 patients",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25569638"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "expression": "Upregulated",
    "significance": "p≤0.005",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "continent": "USA",
    "population": "USA",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non-invasive diagnostic marker for early detection of CRC",
    "expression": "Upregulated",
    "significance": "AUC=0.802, p<0.05",
    "sample_type": "Serum",
    "sample": "Serum samples from 200 CRC patients, 50 advanced adenoma patients, and 80 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23625654"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "The overall and disease-free survival rates of patients with high miR-21 expression were significantly worse than those of patients with low miR-21 expression",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "156 CRC patients, Tissues",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21412018"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlated to shorter overall survival of CRC patients",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Hypoxia biomarker",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "Tumours of patients that had undergone adjuvant 5-FU treatment (n = 11) , Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S",
    "continent": "Europe",
    "population": "UK",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with lower survival",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "27 primary and liver metastasis tumors",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qPCR arrays",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25075017"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "Tissues from 193 CRC patients at the time of surgery",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24632577"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Re-elevation associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-211",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "miR-211 expression level (P = 0.01) was effective on overall survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "continent": "Eurasia",
    "population": "Turkey",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26152286"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: methylated tumor had longer OS than unmethylated",
    "expression": "Downregulated",
    "significance": "p=0.03(methylated vs unmethylated tumors),p=0.35(no significant difference between methylated & unmethylated non-tumor group)",
    "sample_type": "Tissue Cell-line",
    "sample": "71 paired GC & adjacent normal tissues,SGC-7901,MKN-45,AGS,MKN-28,BGC-823,MGC-803,GES-1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR,MSP",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693054"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27619677"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with an unfavorable prognosis",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "99 CRC patients (44 with and 55 without liver metastases)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24616020"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-214 overexpr.  correlated with poor prognosis(p=0.03)",
    "expression": "Upregulated",
    "significance": "p<0.01(tissues,BGC823),p<0.05(SGC7901)",
    "sample_type": "Tissue Cell-line",
    "sample": "120 GC & adjacent non tumorous tissues,GEs1,BGc823,SGC7901",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23834902"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "104 resected tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential biomarker(AUC=0.824,95% CI is 0.699-0.947)",
    "expression": "Upregulated",
    "significance": "p<0.05 (tissues)",
    "sample_type": "Tissue Cell-line",
    "sample": "51 pairs of GC & adjacent non malignant  tissues,GES1,SGC7901,BGC823,NCI-N87,AGS,HGC27,MGC803,MKN28",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23981575"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker: high-risk groupregulated had significantly shorter disease-free survival",
    "expression": "N/A",
    "significance": "p=0.023",
    "sample_type": "Tissue",
    "sample": "Tumor samples from 71 white patients with stage II colon cancer",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "--",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247088"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic biomarker in stage II and III colon cancer -  high levels of miR-215 expression closely associated with poor patient's overall survival.",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "34 paired normal and colon (stage II and III) tumor specimens",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR and immunohistochemistry",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21752725"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Predictive marker for relapse",
    "expression": "Downregulated",
    "significance": "p=0.001",
    "sample_type": "Tissue",
    "sample": "Tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.001(in human gc tissues),p<0.05(in gc cell lines)",
    "sample_type": "Tissue Cell-line",
    "sample": "83 GC & paired normal tissues,SGC7901,HGC27,BGC823,BGC803,MKN28,AGS,GES-1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25869101"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall survival p=0.032",
    "expression": "Downregulated",
    "significance": "p=0.038",
    "sample_type": "Tissue",
    "sample": "Tissue (n=50)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26016795"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma expression(AUC=0.7432)",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma Tissue",
    "sample": "70 GC patients(43 Hp infection & 27 without) & 70 healthy(31 Hp infection & 39 without) plasma, 8 paired GC & adjacent normal tissues,",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC:0.833",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Serum",
    "sample": "Serum(106 EC &60 healthy)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25812647"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC=0.7432",
    "expression": "Downregulated",
    "significance": "AUC=0.7432, p<0.001",
    "sample_type": "Plasma",
    "sample": "60 GC & 60 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognosis - significant association between low miR-218 expression and worse survival",
    "expression": "Downregulated",
    "significance": "Fold-change=0.27, p < 0.001",
    "sample_type": "Tissue",
    "sample": "Tissues from 189 cases and 30 healthy subjects and sera from 30 CRC patients and 30 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24294377"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "40 GC tissues & non tumor mucosa",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20300657"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic factor",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "112 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323107"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: decreased miR-218 expression was independent prognostic marker for overall survival /(p=0.035)in addition to presence of tumor metastasis (p=0.005) and high tumor grade(p=0.000)",
    "expression": "Downregulated",
    "significance": "p=0.026",
    "sample_type": "Serum",
    "sample": "68 GC & 56 healthy serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24944481"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "Tissues, 63 CRC patients",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26442524"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "",
    "sample": "100 ESCC, 100 normal epithelium",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRt-PCr",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.001(tissues)",
    "sample_type": "Tissue Cell-line",
    "sample": "61 paired tissues,Cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26610210"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Reduced miR-22 had a poor overall survival",
    "expression": "Downregulated",
    "significance": "p=0.002",
    "sample_type": "Tissue",
    "sample": "86 patients with primary colorectal cancer",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22492279"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Prognostic: shorter overall survival(p=0.03)",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "98 pairs of GC & adjacent norma mucosa tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23786758"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlated with relapse free survival",
    "expression": "Downregulated",
    "significance": "Fold Change=4 i.e. 76% had reduced expression by 4 folds",
    "sample_type": "Tissue",
    "sample": "118 CRC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28422727"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic survival",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "193 colorectal cancer patients, Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28347238"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive marker for detection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "40 pairs of CRC tissues and 595 stool samples (198 CRCs, 199 polyps and 198 normal controls)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "array followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25233396"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "marker": "diagnostic",
    "marker_details": "Diagnostic: AUC=93.3",
    "expression": "Upregulated",
    "significance": "p=0.012",
    "sample_type": "Tissue",
    "sample": "32 patients for GC & adjacent normal gastric tissues",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26209976"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive marker for diagnosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 103 CRC patients and 37 healthy normal controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20880178"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Non invasive marker for prognosis: prognostic factor for poor overall survival in CRC patients.",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 103 CRC patients and 37 healthy normal controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20880178"
  },
  {
    "miRNA_name": "miR-221-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.850 with 66.1% sensitivity and 88.3% specificity",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma",
    "sample": "114 gc,36 chronic atrophic gastritis and 56 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "iSH (TMA)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25129310"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: increased miR-222 level have reduced disease free survival(p=0.016) and overall survival(p=0.012)",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma",
    "sample": "114 gc,36 chronic atrophic gastritis and 56 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "iSH (TMA)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25129310"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:  plasma expression(AUC=0.9089)",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma Tissue Cell-line",
    "sample": "70 GC patients(43 Hp infection & 27 without) & 70 healthy(31 Hp infection & 39 without) plasma, 8 paired GC & adjacent normal tissues,",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC:0.9089",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma",
    "sample": "60 GC & 60 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma expression level(AUC=0.812,sensitivity=70%,specificity=80%)",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "sample_type": "Plasma Tissue Cell-line",
    "sample": "50 GC & 50 healthy plasma,tissues,cells,GES-1,MKN45",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26629240"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker (Phase II study)",
    "expression": "Upregulated",
    "significance": "Fold Change=17.5, AUC=0.939, p<0.01, sensitivity=76.5% and specificity=96.4%",
    "sample_type": "Stool",
    "sample": "Fecal samples from 17 CRC patients and 28 healthy subjects",
    "continent": "Asia",
    "population": "Singapore",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24841830"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnosis",
    "expression": "Upregulated",
    "significance": "AUC=0.907",
    "sample_type": "Tissue Plasma Stool",
    "sample": "Tissue, stool, and plasma;  62 tissue, 447 stool, and 398 plasma samples were collected from CRC patients and healthy controls",
    "continent": "Asia",
    "population": "Taiwan",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26848774"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlated with poorer overall survival",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "Tissues, 62 patients undergoing radical resection",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25270282"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis of GC in H.pylori positive tissues",
    "expression": "Upregulated",
    "significance": "p<0.001(gc tissue with H.pylori postive vs negative and H.pylori postive vs negative normal gastric tissues and H.pylori postive vs negative SGC7901 ,MKN45 cells)",
    "sample_type": "Tissue Cell-line",
    "sample": "38 Hp +ve GC & 27 Hp -ve GC tissues,15 normal Hp +ve & 12 Hp-ve normal gastric tissues,SGC7901,AGS,MKN45,GES-1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25036956"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum miR-223",
    "expression": "Upregulated",
    "significance": "p=0.009(tissue miR-223)",
    "sample_type": "Serum Tissue",
    "sample": "20 pairs tissues,94 healthy serum,194 ESCC serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-high expression poorer prognosis",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "109 resected  tissues",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22108521"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Strong prognosticator, predicts short-term relapse and poor overall survival",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "115 colorectaladenocarcinomas and 66 adjacent non-cancer mucosae",
    "continent": "Europe",
    "population": "Greece",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25420464"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Shorter overall survival and shorter metastasis free survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "85 CRC samples, CRC tissues from patients with and without metastasis",
    "continent": "Europe",
    "population": "Italy and  UK and  Romania and  Austria",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25804630"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: combined expression of miR-23a and miR-23b confers poor prognosis",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "160 pair of GC tissues & normal mucosa",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25674252"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic :AUC-0.80",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "sample_type": "Plasma",
    "sample": "138 GC & 50 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26835790"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent predictor of  overall survival (p=0.015) &  disease free survival(p=0.004))",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "sample_type": "Plasma",
    "sample": "138 GC & 50 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26835790"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Shorter recurrence-free survival time and poorer overall survival rate",
    "expression": "Downregulated",
    "significance": "p<0.001, AUC=0.842, sensitivity=84.38%; specificity=77.08%",
    "sample_type": "Plasma",
    "sample": "Plasma samples,  96 blood samples were obtained from patients that underwent tumor resection for CRC, 48 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28101227"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: combined expression of miR-23a and miR-23b confers poor prognosis",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "160 pair of GC tissues & normal mucosa",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25674252"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Cell-line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Potential marker for early CRC diagnosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma, 223 patients with colorectal related diseases (111 cancer carcinoma, 59 adenoma, 24 colorectal polyps and 29 inflammatory bowel disease) and 130 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26297223"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-24 independent predictor for exposure group",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "239 FFPE tissues",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26045155"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "High miR-24 expression is independent predictor for exposure status",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "122 tissues atomic bomb survivor",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045155"
  },
  {
    "miRNA_name": "miR-24-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicators for overall survival",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "5 CRC patients who underwent radical resection, Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25502080"
  },
  {
    "miRNA_name": "miR-24-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "High miR-24-3p expression predicts poor disease-free survival (DFS) and overall survival (OS)",
    "expression": "No Significant Difference",
    "significance": "p>0.05",
    "sample_type": "Tissue",
    "sample": "182 colorectal adenocarcinoma specimens and 86 paired non-cancerous colorectal mucosae",
    "continent": "Europe",
    "population": "Greece",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27939727"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Upregulated",
    "significance": "p=0.0157(ESCC tissues),p=0.0093(ESCC cell lines),p<0.0001(preoperative vs healthy plasma),p<0.0005( postoperative vs preoperative plasma)",
    "sample_type": "Tissue Plasma",
    "sample": "Tissues, preoperative,postoperative and healthy plasma",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25117812"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic factor",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "186 patients who underwent surgery matched adjacent normal tissues and 18 normal tissues from normal controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24293092"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high plasma concentration had poor prognosis.",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma Tissue",
    "sample": "Plasma & Primary GC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25043310"
  },
  {
    "miRNA_name": "miR-25-3p",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Independent prognostic factor",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "Metastasized and nonmetastasized tumors N = 43",
    "continent": "Europe",
    "population": "Netherlands and  Germany",
    "detection_method": "Next generation sequencing followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25315964"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.882)",
    "expression": "Downregulated",
    "significance": "p=0.001(tissues),p<0.001(plasma)",
    "sample_type": "Tissue Plasma",
    "sample": "50 paired tissues,80 GC & 80 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "40 pairs of GC & matched adjacent tissues,MKN 28,SGC7901,AGS,MGC803,MKN45,BGC823,GES1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24015269"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor OS",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "FFPE tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27529338"
  },
  {
    "miRNA_name": "miR-26a-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Downregulated",
    "significance": "p=0.013",
    "sample_type": "Plasma",
    "sample": "Plasma, Plasma samples from 61 colorectal cancer patients and 24 normal subjects",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26413249"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p=0.0318",
    "sample_type": "Tissue",
    "sample": "106 paired tissues",
    "continent": "Asia",
    "population": "Taiwan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27078844"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "plasma miR-27a level marker for diagnosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Plasma",
    "sample": "73 paired tissues,35 GC & 35 healthy plasma",
    "continent": "Asia",
    "population": "Korea",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26523130"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator-plasma miR-27a level",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Plasma",
    "sample": "73 paired tissues,35 GC & 35 healthy plasma",
    "continent": "Asia",
    "population": "Korea",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26523130"
  },
  {
    "miRNA_name": "miR-27b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic - Higher expression associated with decreased progression-free survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "continent": "Europe",
    "population": "Norway",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-28-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-29",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "AUC=0.73 ,sensitivity=0.70,specificity=0.68",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "50 tumor & adjacent tumor tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26509997"
  },
  {
    "miRNA_name": "miR-29",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "High miR-29 related with higher OS rate",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "50 tumor & adjacent tumor tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26509997"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues from 90 CRC cases, HCT116, Caco2, HT29, SW620 and SW480",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28209128"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "marker": "Progostic",
    "marker_details": "Patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "continent": "USA",
    "population": "USA",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-299-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "expression": "N/A",
    "significance": "Sensitivity=68% and Specificity=78% (p=0.001)",
    "sample_type": "Tissue",
    "sample": "40 sample pairs of CRC tissue and adjacent noncancerous tissue",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28469363"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - novel noninvasive biomarker for early detection of CRC with liver metastasis.",
    "expression": "Upregulated",
    "significance": "AUC=0.803, At a cutoff value of 0.155, the sensitivity was 75% and the specificity was 75% in discriminating metastatic from non-metastatic patients",
    "sample_type": "Serum",
    "sample": "114 participants including 58 metastatic patients and 56 non-metastatic CRC patients. Serum from 38 CRC patients with liver metastasis and 36 CRC patients without metastasis. For validation - CRC patients without (n=20) and with liver metastasis (n=20)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22018950"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Novel noninvasive biomarkers for early detection",
    "expression": "Upregulated",
    "significance": "AUC=0.844",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,  Fifty-nine age-matched healthy subjects",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-29a was associated with a longer disease-free survival (DFS)",
    "expression": "Upregulated",
    "significance": "p=0.028",
    "sample_type": "Tissue",
    "sample": "110 patients, 51 (46%) with stage I and 59 (54%) with stage II disease, FFPE Tissues",
    "continent": "Asia",
    "population": "Israel",
    "detection_method": "Microarray and qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22426940"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "An evidence against usage of serum miR-17-3p, miR-29a, miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "expression": "No Significant Difference",
    "significance": "p>0.05",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "expression": "Upregulated",
    "significance": "p= 0.001",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "expression": "N/A",
    "significance": "Tissue AUC=0.883, plasma AUC=0.743. sensitivity of 61.4% and a specificity of 72.5%",
    "sample_type": "Tissue and Plasma",
    "sample": "Tissue and Plasma, CRC specimens (tumor and\nadjacent nontumor colon tissues) from 200 patients who had\nundergone resection and 400 Healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26466603"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC = 0.72(95% CI:0.62-0.82 :sensitivity=68%,specificity=68%)",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma",
    "sample": "50 ESCC and 50 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26554762"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Prognostic: higher miR-29c level were correlated with longer disease free survival",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue Cell-line",
    "sample": "166 GC & matched normal gastric  tissues,Ges-1,MGC803,HGC27,BGC823,MKN45",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Gastric tissues derived from normal,chronic gastritis,intestinal metaplasia and GAC",
    "continent": "South America",
    "population": "Brazil",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26877610"
  },
  {
    "miRNA_name": "miR-301a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue Cell-line",
    "sample": "30 pairs of GC & matched non tumor tissues,cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23832550"
  },
  {
    "miRNA_name": "miR-302b",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "50 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24438167"
  },
  {
    "miRNA_name": "miR-30a-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RNA deep sequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-30b was strongly correlated with poor overall survival I patients with EC (p<0.05)",
    "expression": "Downregulated",
    "significance": "p<0.01(tissues,TE-1),p<0.05(ECA109,EC9706,TE-8)",
    "sample_type": "Tissue Cell-line",
    "sample": "37 paired EC and adjacent normal tissues,HEEC,ECA109,EC9706,TE-1,TE-8",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28189678"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic Marker, associated with BRAF and KRAS mutations, High miR-31 expression was related to cancer-specific mortality",
    "expression": "Upregulated",
    "significance": "p=0.009, 335.0",
    "sample_type": "Tissue",
    "sample": "721 CRCs, 381 serrated lesions and 251 non-serrated adenomas",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "miRNA Array analysis, qRT-PCR and Pyro sequencing",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24242331"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic & diagnostic-serum miR-31 level",
    "expression": "Upregulated",
    "significance": "p<0.001(serum),77.8%(tissues)",
    "sample_type": "Tissue Serum",
    "sample": "45 paierd tissues,523 serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRt-pCr",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21658006"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Predicted worse overall survival",
    "expression": "Upregulated",
    "significance": "AUC=0.71, p=0.001",
    "sample_type": "Tissue",
    "sample": "FFPE biopsies from 78 patients",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27271609"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "N/A",
    "significance": "p<0.001(tissues),p<0.05( cell lines)",
    "sample_type": "Tissue Cell-line",
    "sample": "40 tissues ,MGC-803, MKN-45, AGS, SGC- 7901,GES1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27174918"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with prognosis",
    "expression": "N/A",
    "significance": "For Training set 1: p=0.01, for training set 2: p=0.02",
    "sample_type": "Tissue",
    "sample": "87 patients for training set and validation set of 19 FF and 26 FFPE prospectively collected samples from patients with mCRC treated with anti-EGFR antibodies",
    "continent": "Europe",
    "population": "Paris",
    "detection_method": "Genome miRNA profiling on Illumina Human v2 microRNA Expression Beadchips",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24771647"
  },
  {
    "miRNA_name": "miR-32",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "patients with high miR-32 expression had a poor overall survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "35 colorectalcarcinoma samples, 35 corresponding cancer-adjacent tissue samples, 27 colorectal adenoma samples, and 16 normal tissue samples",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24123284"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Potential marker for early CRC diagnosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma, 223 patients with colorectal related diseases (111 cancer carcinoma, 59 adenoma, 24 colorectal polyps and 29 inflammatory bowel disease) and 130 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26297223"
  },
  {
    "miRNA_name": "miR-320e",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Poorer DFS (HR)=1.65; 95% CI=1.27-2.13; P=0.0001) and OS (HR=1.78; 95% CI=1.31-2.41; P=0.0003) in stage III CRC patients",
    "expression": "Upregulated",
    "significance": "Stage III colon cancer, 95% confidence interval (CI)=1.14-1.42; p<0.0001",
    "sample_type": "Tissue",
    "sample": "Tissue, 237 stage II–IV CRC patients treated with 5-FU-based chemotherapy, as well as in normal colonic mucosa from 20 healthy subjects",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26035698"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "GC tissues and cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26359764"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic - Higher expression associated with decreased progression-free survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "continent": "Europe",
    "population": "Norway",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-331",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "expression": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-331",
    "cancer": "Colorectal Cancer",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls",
    "expression": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-331-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Plasma",
    "sample": "74 GC patients (31 patients with recurrence and 43 patients without recurrence).tissues,plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22802949"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Plasma",
    "sample": "74 GC patients (31 patients with recurrence and 43 patients without recurrence).tissues,plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22802949"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "67 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25337272"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic: high expression associated with better DFS,p=0.013(Kaplan -Meir)",
    "expression": "Downregulated",
    "significance": "p<0.001(tissues)",
    "sample_type": "Tissue Cell-line",
    "sample": "231 pared GC &  adjacent non tumor tissues,SGC-7901, MKN-45, BGC-823, AGS, and GES-1)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR,MS-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28239297"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Poor overall survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "miRNA microarray",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318298"
  },
  {
    "miRNA_name": "miR-337-3p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "90 normal gastric & 90 GC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27259238"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-338-3p was associated with unfavorable outcome in disease free survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "40 CRC, adjacent nontumorous tissues and 2 human CRC-derived cell lines (SW-480 and SW-620)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR and Northern blotting",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24824250"
  },
  {
    "miRNA_name": "miR-339-5p",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Independent prognostic factor",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "Metastasized and nonmetastasized tumors N = 43",
    "continent": "Europe",
    "population": "Netherlands and  Germany",
    "detection_method": "Next generation sequencing followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25315964"
  },
  {
    "miRNA_name": "miR-34",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguished groups of patients with polyps from those with advanced cancer",
    "expression": "Upregulated",
    "significance": "Tissue Fold Change=1.71, p=8.50e-6; plasma - FC = 1.90, p-value = 0.001)",
    "sample_type": "Tissue Plasma",
    "sample": "Tissue (public dataset of 40 CRC samples and paired normal tissues), Plasma (validation cohort of 97 subjects)",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25924769"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor: for OS(p=0.001) & DFS(p=0.045)",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Cell-line",
    "sample": "80 tissues,SGC-7901, AGS, MKN-45, MGC-803,GES-1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27374211"
  },
  {
    "miRNA_name": "miR-342",
    "cancer": "Colorectal Cancer",
    "marker": "Screening",
    "marker_details": "Methylation is an early event in colorectal carcinogenesis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "42 colorectal cancers, 9 colorectal adenomas and 16 samples of grossly normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18264139"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "continent": "Europe",
    "population": "Denmark",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker",
    "expression": "N/A",
    "significance": "76.8 % sensitivity and 93.6% specificity of the miR-34a methylation test for detecting CRC using stool samples.",
    "sample_type": "Stool Tissue",
    "sample": "Stool samples and Tissue samples from 82 CRC patients, Control samples from 40 healthy individuals",
    "continent": "Asia",
    "population": "China",
    "detection_method": "Methylation specific PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24573638"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - more significant markers in cancers than in adenomas",
    "expression": "Upregulated",
    "significance": "p=0.0002",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator of GC(p=0.0027, according to multivariate)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "76 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26415802"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low level had a significant impact on OS of patients (p=0.006), expression of miR-34a (P = 0.018), tumor\ndifferentiation (P = 0.021), and TNM stage (P = 0.003) were independent prognostic factors for\npatients with ESCC",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "111 ESCC & adjacent normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26782413"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "40 Gc & 20 normal gastric tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26238271"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "No significant association with prognosis",
    "expression": "Upregulated",
    "significance": "Fold Change=1.42",
    "sample_type": "Tissue",
    "sample": "Tissue (Pairs of primary colon tumor and adjacent non-tumor tissues came from 159 patients and 113 patients from Hong kong)",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and Hong Kong",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25894979"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Poor overall survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "miRNA microarray",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318298"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non-invasive faecal-based screening marker",
    "expression": "Downregulated",
    "significance": "Hypermethylated in 97.5% of  tumours, p=0.0110 and 75% fecal specimens",
    "sample_type": "Stool",
    "sample": "82 of primary colorectal and 28 fecal specimens",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "methylation-specific PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21610744"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Colorectal Cancer",
    "marker": "Screening",
    "marker_details": "Non-invasive faecal-based screening marker",
    "expression": "Downregulated",
    "significance": "Hypermethylated in 97.5% of  tumours, p=0.0110 and 75% fecal specimens",
    "sample_type": "Stool",
    "sample": "82 of primary colorectal and 28 fecal specimens",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "methylation-specific PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21610744"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Significant poor prognosis",
    "expression": "Upregulated",
    "significance": "Fold Change=1.27",
    "sample_type": "Tissue",
    "sample": "Tissue (Pairs of primary colon tumor and adjacent non-tumor tissues came from 159 patients and 113 patients from Hong kong)",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and Hong Kong",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25894979"
  },
  {
    "miRNA_name": "miR-34c",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non-invasive faecal-based screening marker",
    "expression": "Downregulated",
    "significance": "Hypermethylated in 97.5% of  tumours, p=0.0110 and 75% fecal specimens",
    "sample_type": "Stool",
    "sample": "82 of primary colorectal and 28 fecal specimens",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "methylation-specific PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21610744"
  },
  {
    "miRNA_name": "miR-34c",
    "cancer": "Colorectal Cancer",
    "marker": "Screening",
    "marker_details": "Non-invasive faecal-based screening marker",
    "expression": "Downregulated",
    "significance": "Hypermethylated in 97.5% of  tumours, p=0.0110 and 75% fecal specimens",
    "sample_type": "Stool",
    "sample": "82 of primary colorectal and 28 fecal specimens",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "methylation-specific PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21610744"
  },
  {
    "miRNA_name": "miR-34c",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Significant poor prognosis",
    "expression": "Upregulated",
    "significance": "Fold Change=1.25",
    "sample_type": "Tissue",
    "sample": "Tissue (Pairs of primary colon tumor and adjacent non-tumor tissues came from 159 patients and 113 patients from Hong kong)",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and Hong Kong",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25894979"
  },
  {
    "miRNA_name": "miR-361-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "expression": "Downregulated",
    "significance": "Fold Change=3.08, p=0.004",
    "sample_type": "Tissue",
    "sample": "Tissues (60 pairs of CRC and non-tumor samples )",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25965817"
  },
  {
    "miRNA_name": "miR-3651",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic:- OS & DFS both p=0.001(multivariate analysis),low expression poorer OS & DFS p=0.004 and 0.001 respectively(Kaplan Meier)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Fresh ESCC & FFPE tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26210449"
  },
  {
    "miRNA_name": "miR-3651",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-3651-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-3651-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : miR-367 is a potential prognostic biomarker,serum miR-was associated with OS(independent prognostic marker)",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Serum",
    "sample": "35 ESCC & adjacent normal tissues,46 ESCC & 46 healthy serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-372",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Worse overall survival period (p<0.05)",
    "expression": "Downregulated",
    "significance": "p<0.05, AUC=0.854, 81.9 % and 73.3 %.",
    "sample_type": "Serum Tissue",
    "sample": "Serum and tissues in CRC and colorectal precancerous lesions (CPL) patients",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26179262"
  },
  {
    "miRNA_name": "miR-372",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "independent prognostic factor - associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "144 CRC patients",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22456107"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had poore oS(p=0.040)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues,archived sample",
    "continent": "Asia",
    "population": "China",
    "detection_method": "MISH,qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23301089"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum  miR-375",
    "expression": "Downregulated",
    "significance": "p=0.006(tissue miR-375),p=0.007(serum miR-375)",
    "sample_type": "Serum Tissue",
    "sample": "20 pairs tissues,94 healthy serum,194 ESCC serum",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic- expression correlated with poor OS(p=0.048),DFS(p=0.0006)",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR,MSP",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21813472"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-  low miR-375 plasma level",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "50 preoperative plasma",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22519435"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "85 tissues",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25501018"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic :  high levels of miR-375 had improved OS(HR0.47,95%CI 0.26-0.87)",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "Tissues, serum,Kyse170,Eca109",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high miR-375 not correlated with increased survival in both EAC & ESCC",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "195 FFPE of GEC(129 ESCC,61 EAC,5 stomach)",
    "continent": "Europe",
    "population": "Denmark",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26481465"
  },
  {
    "miRNA_name": "miR-376a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Higher expression positively correlated with shorter survival",
    "expression": "Downregulated",
    "significance": "p=0.0294",
    "sample_type": "Tissue",
    "sample": "Tissues from 53 CRC patients and matched matched normals",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25422250"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "expression": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Prognostic: higher expression had  poorer overall survival  and shorter time of reccurence",
    "expression": "Upregulated",
    "significance": "p<0.0001(tissues), p<0.001(cell lines)",
    "sample_type": "Tissue Cell-line",
    "sample": "102 pairs of tumor & normal gastric tissues,cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25998046"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic and Prognostic - Decreaesd in plasma of non-relapsed patients 4-6 months after surgery",
    "expression": "Downregulated",
    "significance": "p=<0.0001",
    "sample_type": "Blood",
    "sample": "Peripheral blood from 65 patients",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24423916"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-378a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Negatively associated with overall survival",
    "expression": "N/A",
    "significance": "p=0.009",
    "sample_type": "Tissue",
    "sample": "Pretreatment cancer tissues in a phase I study and cancer tissues in a phase II study, in which peptide vaccines combined with chemotherapy were given",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "Microarray followed by Revese transcription PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28859241"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic Marker - patients having lower expression had shorter survival",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "96 pairs of FFPE archived CRC and adjacent normal colorectal mucosal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24412052"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Biomarkers for prediction of the efficacy of vaccine treatment for patients with metastatic CRC",
    "expression": "Downregulated",
    "significance": "p=0.025",
    "sample_type": "Tissue",
    "sample": "Phase I study (UMIN clinical trial registration no. UMIN000004948) and phase II trial, 16 patients, Treatment eith HLA-A*2402 restricted peptides peptide cocktail and oxaliplatin-based chemotherapy",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "Microarray",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28789351"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-378a-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic Marker - patients having lower expression had shorter survival",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "96 pairs of FFPE archived CRC and adjacent normal colorectal mucosal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24412052"
  },
  {
    "miRNA_name": "miR-382",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic:-miR-382 level had reverse correlation with poor outcomes,p<0.001(Kaplan Meier)",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "46 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26078564"
  },
  {
    "miRNA_name": "miR-383",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "40 paired intestinal type GAC & adjacent tumor free tissues",
    "continent": "Asia",
    "population": "Iran",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28243881"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC -0.767(95% CI=0.684-0.850)",
    "expression": "Downregulated",
    "significance": "p<0.001(gastric cancer  juices vs benign gastric diseases)",
    "sample_type": "Gastric Juice",
    "sample": "Gastric juice",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22926798"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC -0.767(95% CI=0.684-0.850)",
    "expression": "Upregulated",
    "significance": "p=0.001(mucosa biopsies)",
    "sample_type": "Tissue",
    "sample": "Tisssues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22926798"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "96 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qPCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823855"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had longer OS (p=0.006) & time to relapse (p=0.007)",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue Cell-line",
    "sample": "107 paired tissues, AGS, MKN-28, MKN-45, NCI-N87, HGC-27, SNU-16,SGC-7901,GES1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27016414"
  },
  {
    "miRNA_name": "miR-422a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic factor",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "102 CRC tissues and paired normal mucosa",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27350737"
  },
  {
    "miRNA_name": "miR-423-3p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-tissues expression of miR-423-3p",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Serum Tissue",
    "sample": "67 serum,119 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28254439"
  },
  {
    "miRNA_name": "miR-423-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Potential marker for early CRC diagnosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma, 223 patients with colorectal related diseases (111 cancer carcinoma, 59 adenoma, 24 colorectal polyps and 29 inflammatory bowel disease) and 130 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26297223"
  },
  {
    "miRNA_name": "miR-423-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Early Detection",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Blood",
    "sample": "Blood samples of 53 CRC patients of I-IV stage pre therapy and 50 controls",
    "continent": "N/A",
    "population": "N/A",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25807655"
  },
  {
    "miRNA_name": "miR-424-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "Cell line and tissues",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-425",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma miR-425 is a novel biomarker for ESCC diagnosis",
    "expression": "Upregulated",
    "significance": "p=0.0315(tissues),p=0.047(plasma)",
    "sample_type": "Tissue Plasma Cell-line",
    "sample": "Tissues, plasma,cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26674378"
  },
  {
    "miRNA_name": "miR-425-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-4269",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p=0.006",
    "sample_type": "Tissue",
    "sample": "41 paired GC & adjacent normal samples",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28759040"
  },
  {
    "miRNA_name": "miR-4282",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "CRC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27120047"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p=0.037",
    "sample_type": "Tissue",
    "sample": "88 tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Over-expression of miR-429 was correlated with poor prognosis for CRC",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "5 CRC Tissues for microarray, 141 cases of CRC for real time PCR and 103 cases of CRC for TMA",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR and tissue microarrays",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24237355"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic indicator for chemo-response to 5-FU therapy",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Serum",
    "sample": "78 CRC tissues, 45 serum specimens from CRC patients, tissues from 116 patients receiving 5-FU treatment",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27654003"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues, 110 patients",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23111103"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "40 paired tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26513239"
  },
  {
    "miRNA_name": "miR-431",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "To distinguish Stage IV CRC from controls",
    "expression": "N/A",
    "significance": "AUC=0.896, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-448",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Cell-line",
    "sample": "81 tissues,GES1,NCI-N87, MKN87, SNU16, SGC7901, AGS, MKN28, and MKN45",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26989077"
  },
  {
    "miRNA_name": "miR-449c",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Low expression correlated with low survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26141986"
  },
  {
    "miRNA_name": "miR-449c",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression related with low survival rate",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue  Cell-line",
    "sample": "Tissues and cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26141986"
  },
  {
    "miRNA_name": "miR-4506",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Asociated with poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "CRC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27494869"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker (Phase II study)",
    "expression": "Upregulated",
    "significance": "Fold Change=102, AUC= 0.971, p<0.01, sensitivity=88.2% and specificity=100.0%",
    "sample_type": "Stool",
    "sample": "Fecal samples from 17 CRC patients and 28 healthy subjects",
    "continent": "Asia",
    "population": "Singapore",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24841830"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "expression": "Downregulated",
    "significance": "p<0.001(tissues),p<0.05(cell lines)",
    "sample_type": "Tissue Cell-line",
    "sample": "107 paired tissues,cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26464660"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-451 (HR 2.01; 95 % CI 1.36-2.96; P < 0.001) predicted shorter OS, while tumor status (HR 1.59; 95 % CI 0.73-3.48 P = 0.242), lymph node metastasis (HR 1.41; 95 % CI 0.71-2.82; P = 0.326) and tumor size (HR 1.53; 95 % CI 0.92-2.55; P = 0.099) were not.",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "180gc patient after surgery for microarray preparation,paracancerous normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "tissue microaaray,miRNA-locked nucleic acid ISH",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27605261"
  },
  {
    "miRNA_name": "miR-4539",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression had shorter overall and disease free survival (p<0.05),miR-455-3p expression was independent prognostic factor(p<0.001)",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "ESCC specimen",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Cell-line",
    "sample": "82 paired tissues,MKN45,SGC7901,MGC803",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27451075"
  },
  {
    "miRNA_name": "miR-4775",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "High levels predicted poor survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "544 pairs of FFPE normal and CRC tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR and in situ hybridization",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28095858"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "104 resected tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483-5p",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : upregulated miR-483-5p expression was significantly associated with poor survival of ESCC patients",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "80 pairs of ESCC & adjacent normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28211800"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Early Detection",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Blood",
    "sample": "Blood samples of 53 CRC patients of I-IV stage pre therapy and 50 controls",
    "continent": "N/A",
    "population": "N/A",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25807655"
  },
  {
    "miRNA_name": "miR-485-5p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.01(gc vs normal tissues,SGC7901,BGC-803,BSG-823,BGC-823),p<0.05(MCG-803,MKN-28,MKN-45)",
    "sample_type": "Tissue Cell-line",
    "sample": "60 pairs of GC & adjacent normal tissues,MCG-803,MKN-28,MKN-45,SGC-7901,BGC-803,BSG-823,BGC-823,GES-1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26807169"
  },
  {
    "miRNA_name": "miR-485-5p",
    "cancer": "Gastric Cancer",
    "marker": "prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "132 paired tissues",
    "continent": "N/A",
    "population": "N/A",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27160123"
  },
  {
    "miRNA_name": "miR-486-5p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low or unchanged miR-486-5p expression (P = 0.002), tumor stage (P = 0.001), tumor status (P = 0.001), node status (P = 0.001), tumor size (P = 0.004), and depth of tumor invasion (P = 0.013) were significant negative prognostic predictors for overall survival in patients with GC",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue",
    "sample": "90 GC & adjacent normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "miRNA-LNA ISH",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25793394"
  },
  {
    "miRNA_name": "miR-486-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Biomarkers for prediction of the efficacy of vaccine treatment for patients with metastatic CRC",
    "expression": "Downregulated",
    "significance": "p=0.023",
    "sample_type": "Tissue",
    "sample": "Phase I study (UMIN clinical trial registration no. UMIN000004948) and phase II trial, 16 patients, Treatment eith HLA-A*2402 restricted peptides peptide cocktail and oxaliplatin-based chemotherapy",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "Microarray",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28789351"
  },
  {
    "miRNA_name": "miR-487b",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-487b was associated with better prognosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Primary, non metastatic and liver metastatic lesions (n=34)",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28000854"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low level correlates with poor prognosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24612089"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic factor for progression-free and overall survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "CRC and corresponding adjacent tissues 247 patients",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25270723"
  },
  {
    "miRNA_name": "miR-497",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-497 expression was associated with shorter overall survival(P<0.05)",
    "expression": "Downregulated",
    "significance": "p<0.05(GC tissues and cell lines)",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues,GES1,MKN28,BGC823,SNU-1,SGC7901",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24845562"
  },
  {
    "miRNA_name": "miR-497-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-500",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor: shorter overall survival(p<0.001)",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Cell-line",
    "sample": "10 GC & adjacent matched normal gastric tissues,NGEC-1,NGEC-2,mKN28,MGC803,BGC823,HGC27,SGC7901",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25595906"
  },
  {
    "miRNA_name": "miR-5000-3p",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers of the side population",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Cell-line",
    "sample": "HCT-15, HT-29 and LoVo cells",
    "continent": "Cell-line",
    "population": "Cell-line",
    "detection_method": "micro RNA profiling followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24898979"
  },
  {
    "miRNA_name": "miR-5009-3p",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers of the side population",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Cell-line",
    "sample": "HCT-15, HT-29 and LoVo cells",
    "continent": "Cell-line",
    "population": "Cell-line",
    "detection_method": "micro RNA profiling followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24898979"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "49 EC and 12 normal tissues",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25750296"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "Cell line and tissues",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC for plasma level = 0.835",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma",
    "sample": "100 ESCC & 40 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27345473"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : Kaplan-Meier analysis showed that patient with high miR-506 expression had significant shorter survival time then those with low miR-506 expression",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Plasma",
    "sample": "100 ESCC & 40 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27345473"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26362716"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor overall survival",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "141 GC cases",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25707493"
  },
  {
    "miRNA_name": "miR-509-3p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "100 GC & 64 normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27697095"
  },
  {
    "miRNA_name": "miR-515-5p",
    "cancer": "Rectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "expression": "N/A",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-517a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall and disease-free survival",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "90 pairs of CRC and matched adjacent non-tumor tissue",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27073521"
  },
  {
    "miRNA_name": "miR-518b",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low miR-518b expression were prognostic factor for PFS",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "30 paired tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22958893"
  },
  {
    "miRNA_name": "miR-520c",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "High expression reduced OS(p=0.012) & DFS(p=0.015)",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Cell-line",
    "sample": "90 paired GC & adjacent non tumor tissues,N‐87, SGC‐7901, AGS, SNU‐16, MKN‐45,GES-1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28203525"
  },
  {
    "miRNA_name": "miR-520d-3p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues,SGC7901",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25063221"
  },
  {
    "miRNA_name": "miR-532-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "expression": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-532-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "To distinguish polyps from controls",
    "expression": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers of the side population",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Cell-line",
    "sample": "HCT-15, HT-29 and LoVo cells",
    "continent": "Cell-line",
    "population": "Cell-line",
    "detection_method": "micro RNA profiling followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24898979"
  },
  {
    "miRNA_name": "miR-5692b",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high expression of  miR-5692b associated with poor prognosis(p<0.05)",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "55 pairs of ESCC & adjacent non neoplastic tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "microarray, qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26888510"
  },
  {
    "miRNA_name": "miR-573",
    "cancer": "Rectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "expression": "N/A",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-574-3p",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognosis & Relapse : OS of patients with high expression of miR-574-3p better than with low expression(p=0.004)",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "14 with & 5 without postoperative tumor samples,12 ESCC & adjacent normal epithelia",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27565418"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Rectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "expression": "N/A",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-590-5p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic- low expression had higher OS than high expression(p=0.025)",
    "expression": "Upregulated",
    "significance": "p=0.0003(tissues),p<0.01( cell lines except AGS)",
    "sample_type": "Tissue Cell-line",
    "sample": "50 paired tissues,SGC-7901, MKN-28, MKN-45, BGC-823, AGS,MGC-803,GES-1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27757042"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Serum",
    "sample": "CRC serum and tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "--",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25661360"
  },
  {
    "miRNA_name": "miR-601",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker for early detection",
    "expression": "Downregulated",
    "significance": "Plasma: AUC=0.747,  Sensitivity and specificity of 80.0% and 72.4%, respectively",
    "sample_type": "Plasma",
    "sample": "191 independent individuals (90 CRC, 43 advanced adenoma and 58 healthy participants)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970209"
  },
  {
    "miRNA_name": "miR-613",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Low serum level is diagnostic marker (AUC-0.767+-0.040,sensitivity-81.3%,specificity-62.7%)",
    "expression": "Downregulated",
    "significance": "p<0.001(tissues,serum)",
    "sample_type": "Tissue Serum",
    "sample": "60 pair tissues,75 serum from ESCC and healthy subjects",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26499784"
  },
  {
    "miRNA_name": "miR-613",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with prognosis-worse OS(p=0.018) ,PFS(p=0.035) and p=0.006(multivariate analysis)",
    "expression": "Downregulated",
    "significance": "p<0.001(tissues,serum)",
    "sample_type": "Tissue Serum",
    "sample": "60 pair tissues,75 serum from ESCC and healthy subjects",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26499784"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Decereased expression of miR-625 was positively associated with poor overall survival and an unfavorable prognosis for CRC patients",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "96 pairs of primary CRC and their corresponding adjacent nontumor tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23861214"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic-HR=3.72,95% CI:1.36-8.78,p=0.005",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26309624"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-630 expression was correlated with poor OS in patients with ESCC(p=0.000)",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "sample_type": "Tissue Cell-line",
    "sample": "44 ESCC & adjacent normal tissues,HEEc,ECA109,TE1,EC9706,KYSE70,KYSE3o",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27563011"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall surviva",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "206 patients who underwent surgery",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24981248"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic : independent prognostic factor for overall survival(log rank test,p<0.001)",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "236 gc, matched adjacent normal & 18 cases normal control tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24621930"
  },
  {
    "miRNA_name": "miR-647",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Multivariate Cox regression analysis indicated that low-level expression of miR-647 was an independent prognostic factor for predicting poor survival of GC",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue Cell-line",
    "sample": "109 GC patients,MGC 80-3, MKN45, SNU-5, AGS and KATOIII",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28900514"
  },
  {
    "miRNA_name": "miR-652",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "To distinguish polyps from controls",
    "expression": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-652",
    "cancer": "Colorectal Cancer",
    "marker": "Screening",
    "marker_details": "To distinguish polyps from controls",
    "expression": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "continent": "USA",
    "population": "USA",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-663b",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "AUC=0.841",
    "expression": "Downregulated",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "sample_type": "Plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "expression": "Downregulated",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "sample_type": "Plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "106 GC & adjacent normal tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "ISH,qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26261179"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall survival",
    "expression": "Upregulated",
    "significance": "Overall survival p=0.01",
    "sample_type": "Tissue",
    "sample": "196 CRCs and 14 normal mucosae",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27919977"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "marker": "Prosnostic",
    "marker_details": "Prognosis : low miR-7 expression were associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "85 ESCC & normal samples",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28314263"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - more significant markers in cancers than in adenomas",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-718",
    "cancer": "Esophageal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : -plasma miR-718 AUC of 0.715,0.689 and 0.620 for detection of ESCC patients ,early patients with Tis-T1 or early patient with TNM 0-1 respectively",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "120 ESCC & 51 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26756617"
  },
  {
    "miRNA_name": "miR-720",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Correlated with poorer five year survival",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "sample_type": "Tissue Cell-line",
    "sample": "96 CRC tissues, HCT116 and SW480",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25286763"
  },
  {
    "miRNA_name": "miR-744",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28791400"
  },
  {
    "miRNA_name": "miR-760",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker for early detection",
    "expression": "Downregulated",
    "significance": "Plasma: AUC=0.788, Sensitivity and specificity of 69.2% and 72.4%",
    "sample_type": "Plasma",
    "sample": "191 independent individuals (90 CRC, 43 advanced adenoma and 58 healthy participants)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970209"
  },
  {
    "miRNA_name": "miR-802",
    "cancer": "Rectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "expression": "N/A",
    "significance": "p<0.05",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with a poor clinical outcome",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Tissue (cancer tissues and adjacent normal tissues from 38 patients)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25940709"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognosis : high plasma miR-9 had poor survival(p<0.001)",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "sample_type": "Plasma",
    "sample": "131 ESCC & 131 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "detection_method": "RT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28587538"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Upregulated",
    "significance": "p=0.0016(tissues),p<0.001(EC18,HKESC1,KYSE30,KYSE140,KYSE180,KYSE510),p<0.05(kyse410,KYSE520)",
    "sample_type": "Cell-line",
    "sample": "EC18,HKESC1,KYSE30,KYSE140,KYSE180,KYSE510,KYSE410,KYSE520",
    "continent": "Cell-line",
    "population": "Cell-line",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25375090"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-92",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "expression": "Upregulated",
    "significance": "p<0.0005, sensitivity was 89% and the specificity was 70%",
    "sample_type": "Plasma",
    "sample": "Plasma of 25 patients with CRC and 20 healthy controls.",
    "continent": "Asia",
    "population": "China",
    "detection_method": "MicroRNA profiling and qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19201770"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Novel noninvasive biomarkers for early detection",
    "expression": "Upregulated",
    "significance": "AUC= 0.838, p<0.001",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,  Fifty-nine age-matched healthy subjects",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnosis",
    "expression": "Upregulated",
    "significance": "AUC=0.907",
    "sample_type": "Tissue Plasma Stool",
    "sample": "Tissue, stool, and plasma;  62 tissue, 447 stool, and 398 plasma samples were collected from CRC patients and healthy controls",
    "continent": "Asia",
    "population": "Taiwan",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26848774"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non-invasive diagnostic marker for early detection of CRC",
    "expression": "Upregulated",
    "significance": "AUC=0.786 , p<0.05",
    "sample_type": "Serum",
    "sample": "Serum samples from 200 CRC patients, 50 advanced adenoma patients, and 80 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23625654"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnosttic/Screening marker",
    "expression": "Upregulated",
    "significance": "p<0.0001, sensitivity of 71.6% and specificity of 73.3%",
    "sample_type": "Stool",
    "sample": "Stool samples were collected from 88 patients with CRC, 57 patients with colorectal polyps and 101 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21930727"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator: high miR-92a expression in CRC was independently associated with poor survival",
    "expression": "Upregulated",
    "significance": "AUC=0.786 , p<0.05",
    "sample_type": "Serum",
    "sample": "Serum samples from 200 CRC patients, 50 advanced adenoma patients, and 80 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23625654"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognosis: high miR-92a expression, tumor stage, tumor status, node status, and tumor size were significant negative prognostic predictors for overall survival in patients with GC (P < 0.001, P < 0.001, P = 0.008, P < 0.001, and P = 0.001, respectively)",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "miRNA-LNA in situ hybridization",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26790436"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "High miR-92a expression had a poor overall survival",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "82 patients with colorectal carcinomas",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22772712"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "marker": "Screening",
    "marker_details": "Diagnosttic/Screening marker",
    "expression": "Upregulated",
    "significance": "p<0.0001, sensitivity of 71.6% and specificity of 73.3%",
    "sample_type": "Stool",
    "sample": "Stool samples were collected from 88 patients with CRC, 57 patients with colorectal polyps and 101 healthy controls",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21930727"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "An evidence against usage of serum miR-17-3p, miR-29a, miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "expression": "No Significant Difference",
    "significance": "p>0.05",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "expression": "Upregulated",
    "significance": "p= 0.004",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "continent": "Europe",
    "population": "Germany",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-92a-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-92a-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "No significant association",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-92a-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-92b-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated closely with poor overall survival in patients with colon cancer",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "138 paired samples of tumoral and nontumoral colon tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23354160"
  },
  {
    "miRNA_name": "miR-93-5p",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "expression": "N/A",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "continent": "USA",
    "population": "USA",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-938",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-9-3p",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue Cell-line",
    "sample": "100 matched tissues,HGC27,MGC803,BGC823,SGC7901,GES1",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28418879"
  },
  {
    "miRNA_name": "miR-940",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma-miR-940",
    "expression": "Downregulated",
    "significance": "p<0.0001(plasma), p=0.0015( tissues)",
    "sample_type": "Plasma Tissue",
    "sample": "30plasma initial set & 80 plasma in validation set,34 tissues",
    "continent": "Asia",
    "population": "Hong Kong",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26456959"
  },
  {
    "miRNA_name": "miR-940",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue Cell-line",
    "sample": "38 paired tissues and GES-1,SNU16,MKN87,KATOIII,SGC7901,SNU216,MKN28,MGC803,HGC27",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26317898"
  },
  {
    "miRNA_name": "miR-942",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic: lower expression had longer survival time",
    "expression": "Upregulated",
    "significance": "p=0.002(TCGA),p<0.05(cell lines)",
    "sample_type": "Tissue Cell-line",
    "sample": "10 pairs tissues,TCGA data,NEEC1,NEEC2,EC18,HKESC1,TE1,KYSE520,EC9706,KYSE510,KYSE180,108CA,ECA109,KYSe410,KYSE30",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR,microarray(TCGA)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25844602"
  },
  {
    "miRNA_name": "miR-944",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Corrrelated with prognosis",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "CRC Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28498456"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Predicts poor disease-free and overall survival",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "108 primary colorectal adenocarcinoma samples and 54 paired non-cancerous colorectal tissue specimens",
    "continent": "Europe",
    "population": "Greece",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27044381"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "continent": "USA",
    "population": "USA",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Distinguished stage I-IV CRC from healthy controls, Prognosis-overall survival",
    "expression": "Upregulated",
    "significance": "AUC=0.74",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV), 187 CRC cases and 47 healthy controls",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Distinguished stage I-IV CRC from healthy controls, Prognosis-overall survival",
    "expression": "Upregulated",
    "significance": "AUC=0.74",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV), 187 CRC cases and 47 healthy controls",
    "continent": "USA",
    "population": "USA",
    "detection_method": "qRT-PCR",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-99a",
    "cancer": "Esophageal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "expression": "Downregulated",
    "significance": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "101 surgical tissues,3ESCC cell lines",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292834"
  },
  {
    "miRNA_name": "miR-99a-3p",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with Progression-free survival (PFS) and disease free survival",
    "expression": "Upregulated",
    "significance": "p=0.027",
    "sample_type": "Tissue",
    "sample": "Tumor tissue samples of 78 patients with metastatic CRC",
    "continent": "Europe",
    "population": "Spain",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "Panel (Let-7c miR-99a miR-125b)",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with  significantly longer progression-free survival and longer overall survival",
    "expression": "Panel",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "183 mCRC cases from 2 independent cohorts (cohort 1: 74 cases; validation cohort: 109 cases) treated with cetuximab or panitumumab",
    "continent": "Europe",
    "population": "Italy",
    "detection_method": "miRNA arrays",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24503111"
  },
  {
    "miRNA_name": "Panel (miR 21,135a, 335, 206 and let-7a)",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for presence of metastasis",
    "expression": "Panel",
    "significance": "Specificity of 87% and sensitivity of 76% for the presence of metastases",
    "sample_type": "Tissue",
    "sample": "15 primary tumours with adjacent normal tissue from patients that were disease-free at 4 years (cohort A) and 19 paired primary tumours with corresponding liver metastases (cohort B)",
    "continent": "North America",
    "population": "Canada",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22120473"
  },
  {
    "miRNA_name": "Panel (miR-1, miR9, miR124, and miR137)",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers for Identifying High-Risk Patients with Ulcerative Colitis-associated Colorectal Cancer",
    "expression": "Downregulated",
    "significance": "AUC=0.78",
    "sample_type": "Tissue",
    "sample": "387 colorectal tissue specimens, collected from 238 patients with UC (152 without neoplasia, 17 with dysplasia, and 69 with UC-associated colorectal cancer,validation study of samples from 90 patients without UC and 61 patients with UC-associated dysplasia or cancer",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "bisulfite pyrosequencing analysis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28847750"
  },
  {
    "miRNA_name": "Panel (miR-107, miR-21, miR-196a,\nmiR-26b, miR-9, miR-142-3p, miR-30b, miR-150, miR-191 and miR-17)",
    "cancer": "Gastric Cancer",
    "marker": "Prognostic",
    "marker_details": "Prognostic for miR-107worse survical rates with OS(P=0.002) and DFS(P=0.017)",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "sample_type": "Tissue",
    "sample": "161 GC & adjacent normal tissues(for miR-107 real time pcr) and 5 pairs of GC & adjacent normal for panels of miRNA expression study",
    "continent": "Asia",
    "population": "Japan",
    "detection_method": "qRT-PCR based miRNA array,Real timT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22407237"
  },
  {
    "miRNA_name": "Panel (miR-145, miR-106a and miR-17-3p)",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Shorter disease-free survival (DFS) (P < 0.0001 for miR-17-3p and P = 0.001 for miR-106a)",
    "expression": "N/A",
    "significance": "p=< 0.0001, AUC=0.886, AUC=0.85",
    "sample_type": "Serum",
    "sample": "Serum from pre- and post-operative CRC patients and normal subjects, 175 stage II/III CRC patients",
    "continent": "Asia",
    "population": "China",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26250939"
  },
  {
    "miRNA_name": "Panel (miR-16,miR-25,miR-92a,miR-451,miR-486-5p)",
    "cancer": "Gastric Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: miR-16,miR-25,miR-92a,miR-451,miR-486-5p panel in plasma is potential biomarker for early detection of GC",
    "expression": "Upregulated",
    "significance": "N/A",
    "sample_type": "Plasma",
    "sample": "Gastric non cardia adenocarcinoma;GNCA, plasma: training set(40 GNCA & 40 control), validation set(48 GNCA & 102 control)",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24595006"
  },
  {
    "miRNA_name": "Panel (miR-193a-3p, miR-23a and miR-338-5p)",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "expression": "Panel",
    "significance": "AUC=0.887, 80.0% sensitivity, 84.4% specificity and 83.3% accuracy",
    "sample_type": "Tissue",
    "sample": "Paired cancer tissues (n = 30) and blood samples (CRC, n = 70; control, n = 32)",
    "continent": "Asia",
    "population": "Malaya",
    "detection_method": "microarray followed by qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23758639"
  },
  {
    "miRNA_name": "Panel (miR-200c and miR-18a)",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "expression": "Upregulated",
    "significance": "Combined AUC of 0.839 with 84.6% sensitivity and 75.6% specificity",
    "sample_type": "Plasma",
    "sample": "Plasma from 78 patients with 86 healthy volunteers",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24649179"
  },
  {
    "miRNA_name": "Panel (miR-21, let-7g, miR-31, miR-92a, miR-181b, and miR-203)",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Non invasive biomarker for diagnosis",
    "expression": "Panel",
    "significance": "AUC=0.923",
    "sample_type": "Serum",
    "sample": "Serum samples from 83 CRCs and 59 controls in validation set",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24709885"
  },
  {
    "miRNA_name": "Panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "To classify patients at high risk of disease progression from those at low risk",
    "expression": "Panel",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "Panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "To classify patients at high risk of disease progression from those at low risk",
    "expression": "Panel",
    "significance": "N/A",
    "sample_type": "Tissue",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "Panel (miR-23a-3p, miR-27a-3p, miR-142-5p and miR-376c-3p)",
    "cancer": "Colon Cancer",
    "marker": "Prognostic",
    "marker_details": "Early diagnostic and prognostic panel",
    "expression": "Panel",
    "significance": "AUC=0.922, Sensitivity=89% and specificity=81%",
    "sample_type": "Serum",
    "sample": "427 colon cancer patients and 276 healthy donors, Serum",
    "continent": "Europe",
    "population": "Czech Republic",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27485599"
  },
  {
    "miRNA_name": "Panel (mir-23b, mir-365-1 and mir-365-2)",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Associated with Prognosis",
    "expression": "Panel",
    "significance": "N/A",
    "sample_type": "TCGA Dataset",
    "sample": "253 samples from TCGA Dataset",
    "continent": "N/A",
    "population": "TCGA Data",
    "detection_method": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26269151"
  },
  {
    "miRNA_name": "Panel (miR-29a and miR-92a)",
    "cancer": "Colorectal Cancer",
    "marker": "Diagnostic",
    "marker_details": "Novel noninvasive biomarkers for early detection",
    "expression": "Upregulated",
    "significance": "p<0.001, AUC=0.883, Sensitivity=83.0% and Specificity=84.7%",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,  Fifty-nine age-matched healthy subjects",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "Panel (miR-375, miR-424 and miR-92a)",
    "cancer": "Colon Cancer",
    "marker": "Diagnostic",
    "marker_details": "Classifier : To discriminate carcinomas from adenomas",
    "expression": "Panel",
    "significance": "AUC=0.968,  accuracy of 94.1%",
    "sample_type": "Tissue",
    "sample": "FFPE colorectal tissue samples from 91 surgical resections",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22535378"
  },
  {
    "miRNA_name": "Panel (miR-409-3p, miR-7, and miR-93)",
    "cancer": "Colorectal Cancer",
    "marker": "Prognostic",
    "marker_details": "Early Detection",
    "expression": "Panel",
    "significance": "AUC=0.897",
    "sample_type": "Plasma",
    "sample": "80 plasma samples for microarray and 161 training and validation plasma samples by real time PCR",
    "continent": "Asia",
    "population": "China",
    "detection_method": "qRT-PCR",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23456911"
  }
]